SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
SCHEDULE 13D
(Rule 13d-101)
Under the Securities Exchange Act of 1934
(Amendment No. 1)(1)
SteriGenics International, Inc.
(Name of Issuer)
Common Stock, $.001 par value
(Title of Class of Securities)
85915R105
(CUSIP Number)
Mr. Pierre Mottet Ramon P. Marks, Esq.
Ion Beam Applications S.A. Dorsey & Whitney LLP
Chemin du Cyclotron, 3 250 Park Avenue
B-1348 Louvain-la-Neuve, Belgium New York, New York 10177
011-32-10-47-5855 (212) 415-9200
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 10, 1999
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
[_].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(g), for other
parties to whom copies are to be sent.
(continued on following pages)
(page 1 of 10 pages)
- ----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 85915R105 13D Page 2 of 11 Pages
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Ion Beam Applications S.A.
Tax I.D. Number: N/A
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [_]
3. SEC USE ONLY
4. SOURCE OF FUNDS
WC, BK
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) [_]
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Belgium
NUMBER OF 7. SOLE VOTING POWER
SHARES
BENEFICIALLY 751,300 shares
OWNED BY
EACH 8. SHARED VOTING POWER
REPORTING
PERSON WITH 2,494,312 shares
9. SOLE DISPOSITIVE POWER
751,300 shares
10. SHARED DISPOSITIVE POWER
2,494,312 shares
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,245,612 shares
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
40.54%
14. TYPE OF REPORTING PERSON
CO
<PAGE>
CUSIP No. 85915R105 13D Page 3 of 11 Pages
Pages
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Belgabeam S.A.
Tax I.D. Number: N/A
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [_]
3. SEC USE ONLY
4. SOURCE OF FUNDS
N/A
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) OR 2(e)
[_]
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Belgium
NUMBER OF 7. SOLE VOTING POWER
SHARES
BENEFICIALLY 0 shares
OWNED BY
EACH 8. SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
9. SOLE DISPOSITIVE POWER
0 shares
10. SHARED DISPOSITIVE POWER
0 shares
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 shares
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14. TYPE OF REPORTING PERSON
CO
<PAGE>
CUSIP No. 85915R105 13D Page 4 of 11 Pages
Pages
Item 1. Security and Issuer
This statement relates to the common stock, par value $.001 ("Common
Stock") of SteriGenics International, Inc. (hereinafter referred to as the
"Issuer"), a Delaware corporation whose principal executive offices are at 4020
Clipper Court, Fremont, CA 94538.
Item 2. Identity and Background
(a) - (c) and (f) This First Amended Statement on Schedule 13D is filed on
behalf of Ion Beam Applications S.A. ("IBA") and Belgabeam S.A., the largest
single shareholder of IBA, owning approximately 35.47% of IBA ("Belgabeam," and
together with IBA, the "Reporting Persons" and each, a "Reporting Person"). More
than 75% of the equity of Belgabeam is owned by employees of IBA. The following
table sets forth the name, the State or other place or organization, the
principal business, the address of such principal business and the address of
the principal office of the Reporting Persons.
Name: ION BEAM APPLICATIONS S.A.
Place of organization: Belgium
Principal business: A Belgian public company engaged primarily
in the development and marketing of particle
accelerators used in medical and industrial
applications
Address of principal business: Chemin du Cyclotron, 3
B-1348 Louvain-la-Neuve, Belgium
Address of principal office: Chemin du Cyclotron, 3
B-1348 Louvain-la-Neuve, Belgium
Name: BELGABEAM S.A.
Place of organization: Belgium
Principal business: Single largest shareholder of Ion Beam
Applications S.A., a Belgian public company,
engaged primarily in the development and
marketing of particle accelerators used in
medical and industrial applications
Address of principal business: Chemin du Cyclotron, 3
<PAGE>
CUSIP No. 85915R105 13D Page 5 of 11 Pages
Pages
B-1348 Louvain-la-Neuve, Belgium
Address of principal office: Chemin du Cyclotron, 3
B-1348 Louvain-la-Neuve, Belgium
The name, citizenship, business address and present principal occupation or
employment of each executive officer and director of each of the Reporting
Persons, as well as the name, principal business and address of the corporation
or other organization in which such occupation or employment is conducted, are
set forth in Exhibit A.
(d) - (e) During the five years prior to the date hereof, neither the
Reporting Persons nor, to the best of their knowledge, any executive officer or
director of the Reporting Persons, (i) has been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors) or (ii) has
been a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction, as a result of which such person was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, Federal or state securities laws or finding
any violation with respect to such laws.
Item 3 of the Existing Schedule 13D is amended in its entirety to read as
follows:
Item 3. Source and Amount of Funds or Other Consideration
Merger
Pursuant to the Offer and Merger (as defined and more fully described in
Item 4 below), IBA Acquisition Corp. ("Acquisition"), a Delaware corporation
that is a wholly-owned subsidiary of Ion Beam Applications G.P. ("GP"), a
Delaware general partnership of which IBA is the controlling general partner,
will, subject to the terms and conditions contained in the Merger Agreement (as
defined and more fully described in Item 4 below), acquire all of the issued and
outstanding shares of capital stock of the Issuer, with the result that
following the Merger, IBA and GP will own and will ultimately control all of the
outstanding capital stock of the Issuer.
Pursuant to the Merger Agreement, it is expected that the acquisition cost
will be approximately $214,000,000. It is anticipated that the source of the
required funds will be obtained through a combination of bank financing and
IBA's working capital.
Pursuant to the Merger Agreement, certain stockholders of the Issuer
entered into a Stockholders' Agreement (as defined in Item 4 below), pursuant to
which IBA acquired an irrevocable proxy to vote the shares of Common Stock of
the Issuer on certain matters, including mergers, consolidations and other
similar extraordinary corporate transactions involving the Issuer, and an option
to acquire all of the shares of Common Stock of the Issuer owned by of such
stockholders under certain conditions as more fully described in Item 4 below.
None of the Reporting Persons has paid to the
<PAGE>
CUSIP No. 85915R105 13D Page 6 of 11 Pages
Pages
Principal Stockholders any funds in connection with the execution of the
Stockholders' Agreement. The Stockholders' Agreement was entered into to induce
IBA, GP and Acquisition to enter into, and in consideration for their entering
into, the Merger Agreement with the Issuer.
ITEM 4 OF THE EXISTING SCHEDULE 13D IS AMENDED IN ITS ENTIRETY TO READ AS
FOLLOWS:
Item 4. Purpose of the Transaction
Merger Agreement
On June 7, 1999, the Board of Directors of IBA approved a proposal to enter
into a Merger Agreement (the "Merger Agreement") with the Issuer, pursuant to
which Acquisition would, subject to certain conditions, make a tender offer (the
"Offer") for all of the outstanding shares of the Issuer not owned by IBA or any
of its subsidiaries or affiliates at a cash price of $27.00 per share, net to
the seller (the "Offer Price").
On June 10, 1999, IBA, GP and Acquisition entered into the Merger Agreement
with the Issuer. A copy of the Merger Agreement is filed herewith as Exhibit
2.01 and the summary description of the Merger Agreement set forth herein is
qualified in its entirety by reference to the Merger Agreement. A copy of the
press release issued by IBA on June 11, 1999, announcing the execution of the
Merger Agreement, is filed herewith as Exhibit 99.1.
The Offer will commence within five (5) business days and will be made upon
the terms and subject to certain conditions set forth in the Merger Agreement
and to be set forth in an Offer to Purchase and a related Letter of Transmittal.
Upon completion of the Offer, Acquisition will merge with and into the Issuer
and the Issuer will continue as the surviving corporation and become a
wholly-owned subsidiary of GP (the "Merger"). Pursuant to the Merger all
remaining outstanding shares of Common Stock of the Issuer, except for shares
held by IBA or any of its subsidiaries and affiliates, and shares held by
stockholders who may exercise their rights of appraisal under Delaware law, will
be converted into the right to receive a cash payment of $27.00 per share. All
currently outstanding options held by employees of the Issuer will vest upon the
effective time of the Merger and convert into the right to receive a cash
payment equal to the difference between $27.00 and the exercise price of the
option (to the extent such exercise price is less than $27.00).
The purpose of the Offer and Merger is for IBA to acquire control of the
Issuer and to own, through GP, all of the outstanding shares of capital stock of
the Issuer.
<PAGE>
CUSIP No. 85915R105 13D Page 7 of 11 Pages
Pages
Pursuant to the Merger Agreement, upon consummation of the Offer IBA will
have its designees appointed to the board of directors of the Issuer such that
the designees of IBA will constitute a majority of the board of directors of the
Issuer.
The proposed transactions would, if and when consummated, result in the
Issuer's Common Stock ceasing to be authorized for listing on the NASDAQ
Exchange and becoming eligible for termination of registration under Section
12(g)(4) of the Exchange Act.
Stockholders' Agreement
Beneficial ownership of certain of the Common Stock which is the subject of
this Schedule 13D may be deemed to have been acquired through the execution of a
Stockholders' Agreement (the "Stockholders' Agreement") dated as of June 10,
1999 among IBA, GP, Acquisition and certain of the stockholders of the Issuer
named on the signature pages thereto (collectively, the "Principal
Stockholders").
Pursuant to the Stockholders' Agreement each Principal Stockholder has
agreed to vote for approval of the transactions contemplated by the Merger
Agreement. A copy of the Stockholders' Agreement is filed herewith as Exhibit
9.01 and the summary description set forth herein is qualified in its entirety
by reference to the Merger Agreement. Each Principal Stockholder also agreed to
vote during the period commencing as of the date of the Stockholders' Agreement
and continuing until the first to occur of the Closing Time (as defined in the
Merger Agreement) or 45 days after the termination of the Merger Agreement in
accordance with its terms (i) against any action or agreement intended or
reasonably expected to impede or interfere with the Offer or Merger or result in
any breach by the Issuer (or any subsidiary) of any obligation or agreement
under the Merger Agreement or a reduction in the benefits to the Issuer, and
against any alternative acquisition proposal; and except as specifically
requested in writing in advance by Parent , (ii) against the following actions
(other than the Merger and the transactions contemplated by the Merger Agreement
and the Stockholders' Agreement): (A) any extraordinary corporate transaction,
such as a merger, consolidation or other business combination involving the
Issuer or any of its subsidiaries or affiliates; (B) a sale, lease, transfer or
disposition by the Issuer or any of its subsidiaries of any assets outside the
ordinary course of business or any assets which in the aggregate are material to
the Issuer and its subsidiaries taken as a whole, or a reorganization,
recapitalization, dissolution or liquidation of the Issuer or any of its
subsidiaries or affiliates; (C)(1) any change in the present capitalization of
the Issuer or any amendment of the Issuer's charter or By-Laws; (2) any other
material change in the Issuer's or any of its subsidiaries' corporate structure
or business; or (3) any other action that is intended, or could reasonably be
expected, to impede, interfere with, delay, postpone or materially adversely
affect the Offer, the Merger or the transactions contemplated by the
Stockholders' Agreement or the Merger Agreement.
Each Principal Stockholder has also granted an irrevocable proxy to
designees of IBA, which may be exercised during the period commencing as of the
date of the Stockholders Agreement and continuing until the first to occur of
the Closing Time (as defined in the Merger Agreement) or 45 days after the
termination of the Merger in accordance with its terms, granting IBA the
authority to similarly vote the shares of the Common Stock owned by such
Principal Stockholder. Each Principal Stockholder has also granted to IBA an
irrevocable option (collectively, the "Options") to purchase all shares held of
record or beneficially owned by each such Principal Stockholder at a purchase
price per share equal to the higher of $27.00 or the price offered by
Acquisition in the Offer. IBA may exercise the Options following the occurrence
of certain events as described in the Stockholders' Agreement. THe Options
expire upon the earliest of (i) the closing of the Merger, (ii) 45 days after
the occurrence of an event triggering the exercisability of the Options, or
(iii) 45 days after the termination of the Merger Agreement in accordance with
certain of its provisions, and may be extended in certain circumstances.
As a result of the Stockholder's Agreement, IBA has shared power to vote an
aggregate of 2,494,312 shares of the Common Stock for the limited purposes
described above,
<PAGE>
CUSIP No. 85915R105 13D Page 8 of 11 Pages
Pages
and such shares constitute approximately 31.16% of the issued and outstanding
shares of the Common Stock as of May 31, 1999. The Stockholders' Agreement
terminates upon the completion of the Merger or the termination of the Merger
Agreement, whichever occurs first.
Except as described in this Item 4 and elsewhere in this Schedule 13D, IBA
has no present plans or proposals that relate to or would result in: (a) the
acquisition by any person of additional securities of the Issuer, or the
disposition of securities of the Issuer; (b) an extraordinary corporate
transaction, such as a merger, reorganization or liquidation, involving the
Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount
of assets of the Issuer or any of its subsidiaries; (d) any change in the
present board of directors or management of the Issuer, including any plans or
proposals to change the number or term of directors or to fill any existing
vacancies on the board; (e) any material change in the present capitalization or
dividend policy of the Issuer; (f) any other material change in the Issuer's
business or corporate structure; (g) changes in the Issuer's charter, by-laws or
instruments corresponding thereto or other actions which may impede the
acquisition of control of the Issuer by any person; (h) causing a class of
securities of the Issuer to be delisted from a national securities exchange or
to cease to be authorized to be quoted in an interdealer quotation system of a
registered national securities association; (i) a class of equity securities of
the Issuer's becoming eligible for termination of registration pursuant to
Section 12(g)(4) of the Act, as amended; or (j) any action similar to those
enumerated above.
ITEM 5 OF THE EXISTING SCHEDULE 13D IS AMENDED IN ITS ENTIRETY TO READ AS
FOLLOWS:
Item 5. Interest in Securities of the Issuer
(a) and (b) As of June 10, 1999, the Reporting Persons may be deemed to
beneficially own in the aggregate 3,245,612 shares of Common
Stock, representing approximately 40.54% of the outstanding
shares of Common Stock, as at May 31, 1999. Of the 751,300
shares of Common Stock beneficially owned by IBA, IBA
possesses the sole power to dispose of, direct the
disposition of and vote 751,300 shares of Common Stock, and
possesses the shared power (with the Principal Stockholders)
to dispose of, direct the disposition of and vote 2,494,312
shares of Common Stock. Belgabeam's beneficial ownership is
indirect through IBA. To the knowledge of the Reporting
Person, and except as otherwise disclosed in this Amendment,
none of the executive officers or directors of the Reporting
Persons is the beneficial owner of any shares of Common
Stock, and no transaction in the Common Stock has been
effected by any such individual during the past sixty (60)
days.
<PAGE>
CUSIP No. 85915R105 13D Page 9 of 11 Pages
Pages
(c) None of the Reporting Persons has effected any transaction in the
Issuer's stock since the filing of the Schedule 13D on March 11, 1999.
The following transactions effected in the Issuer's Common Stock were
effected in the last 60 days by Philippe Janssens de Varebeke, a
director of IBA:
Date No. of Shares Price per Share Where/How Effected
---- ------------- --------------- ------------------
4/12/99 2,000 $10.25 Open Market Purchase
6/1/99 4,600 $16.1454 Open Market Purchase
6/1/99 3,200 $16.5625 Open Market Purchase
6/2/99 2,300 $17.6187 Open Market Purchase
(d) Not applicable.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer.
The information contained in Items 3 and 4 above, and the exhibits referred
to therein, are incorporated by reference in this Item 6.
Item 7. Material to be Filed as Exhibits.
*Exhibit A. Amended and Restated Information Concerning Reporting Persons'
Officers and Directors.
Exhibit 2.01 Merger Agreement dated as of June 10, 1999, among IBA, GP,
Acquisition and the Issuer.
Exhibit 9.01 Stockholders' Agreement dated as of June 10, 1999, among IBA,
GP, Acquisition and the Stockholders identified therein
Exhibit 99.1 Press Release dated as of June 10, 1999
*Filed as Exhibit A to Schedule 13D, dated March 11, 1999, and filed with the
Commission on March 11, 1999, and incorporated herein by reference.
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of the knowledge and belief of
each of the undersigned, the undersigned certify that the information set forth
in this statement is true, complete and correct.
Date: June 11, 1999
ION BEAM APPLICATIONS S.A.
By:
--------------------------------
Pierre Mottet, its
Chief Executive Officer
BELGABEAM S.A.
By:
--------------------------------
Eric de Lamotte, its
Director
<PAGE>
CUSIP No. 85915R105 13D Page 11 of 11 Pages
Pages
Exhibit Index
*Exhibit A. Information Concerning Reporting Persons' Officers and Directors.
Exhibit 2.01 Merger Agreement dated as of June 10, 1999, among IBA, GP,
Acquisition and the Issuer
Exhibit 9.01 Stockholders' Agreement dated as of June 10, 1999, among IBA, GP,
Acquisition and the Stockholders Identified Therein
Exhibit 99.1 Press Release dated as of June 10, 1999
- --------------------------------------------------------------------------------
MERGER AGREEMENT
DATED AS OF JUNE 10, 1999
AMONG
ION BEAM APPLICATIONS S.A.
ION BEAM APPLICATIONS G.P.
IBA ACQUISITION CORP.
AND
STERIGENICS INTERNATIONAL, INC.
- --------------------------------------------------------------------------------
<PAGE>
TABLE OF CONTENTS
Page
----
ARTICLE 1 THE OFFER......................................................1
SECTION 1.1. THE OFFER......................................................1
SECTION 1.2. COMPANY ACTION.................................................3
SECTION 1.3. BOARDS OF DIRECTORS AND COMMITTEES; SECTION 14(F)..............4
ARTICLE 2 THE MERGER.....................................................5
SECTION 2.1. THE MERGER.....................................................5
SECTION 2.2. CLOSING OF THE MERGER..........................................5
SECTION 2.3. EFFECTIVE TIME.................................................5
SECTION 2.4. EFFECTS OF THE MERGER..........................................6
SECTION 2.5. CHARTER AND BYLAWS.............................................6
SECTION 2.6. DIRECTORS......................................................6
SECTION 2.7. OFFICERS.......................................................6
SECTION 2.8. CONVERSION OF SHARES...........................................6
SECTION 2.9. PAYMENT OF CASH MERGER CONSIDERATION...........................7
SECTION 2.10. STOCK OPTIONS; PURCHASE PLAN...................................8
ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF THE COMPANY..................8
SECTION 3.1. ORGANIZATION AND QUALIFICATION; SUBSIDIARIES...................9
SECTION 3.2. CAPITALIZATION OF THE COMPANY AND ITS SUBSIDIARIES.............9
SECTION 3.3. AUTHORITY RELATIVE TO THIS AGREEMENT; RECOMMENDATION..........10
SECTION 3.4. SEC REPORTS; FINANCIAL STATEMENTS.............................11
SECTION 3.5. INFORMATION SUPPLIED..........................................11
SECTION 3.6. CONSENTS AND APPROVALS; NO VIOLATIONS.........................11
SECTION 3.7. COMPLIANCE WITH APPLICABLE LAW................................12
SECTION 3.8. NO UNDISCLOSED LIABILITIES; ABSENCE OF CHANGES................12
SECTION 3.9. LITIGATION....................................................13
SECTION 3.10. YEAR 2000 COMPLIANCE..........................................13
SECTION 3.11. EMPLOYEE BENEFIT PLANS, LABOR MATTERS.........................14
SECTION 3.12. ENVIRONMENTAL LAWS AND REGULATIONS............................15
SECTION 3.13. TAXES.........................................................16
SECTION 3.14. PROPERTIES....................................................17
SECTION 3.15. MATERIAL CONTRACTS AND COMMITMENTS............................17
SECTION 3.16. INTANGIBLE PROPERTY...........................................19
SECTION 3.17. BROKERS.......................................................19
SECTION 3.18 CERTAIN BUSINESS PRACTICES....................................20
SECTION 3.19. APPLICABILITY OF STATE TAKEOVER STATUTES......................20
SECTION 3.20 AMENDMENT TO THE RIGHTS AGREEMENT.............................20
SECTION 3.21 OPINION OF FINANCIAL ADVISOR..................................20
SECTION 3.22 EMPLOYEES.....................................................20
ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF PARENT AND ACQUISITION......21
SECTION 4.1. ORGANIZATION..................................................21
SECTION 4.2. AUTHORITY RELATIVE TO THIS AGREEMENT..........................21
SECTION 4.3. INFORMATION SUPPLIED..........................................22
SECTION 4.4. FINANCING.....................................................22
SECTION 4.5. CONSENTS AND APPROVALS; NO VIOLATIONS.........................22
ARTICLE 5 COVENANT......................................................23
i
<PAGE>
SECTION 5.1. INTERIM OPERATIONS............................................23
SECTION 5.2. STOCKHOLDERS' MEETING.........................................25
SECTION 5.3. OTHER POTENTIAL ACQUIRERS.....................................25
SECTION 5.4. INTENTIONALLY OMITTED.........................................27
SECTION 5.5. ACCESS TO INFORMATION.........................................27
SECTION 5.6. FURTHER ACTIONS...............................................27
SECTION 5.7. HSR MATTERS...................................................28
SECTION 5.8. PUBLIC ANNOUNCEMENTS..........................................28
SECTION 5.9. EMPLOYEE BENEFIT MATTERS; COMPANY STOCK OPTION................29
SECTION 5.10. NOTIFICATION OF CERTAIN MATTERS...............................29
SECTION 5.11. GUARANTEE OF PERFORMANCE......................................29
SECTION 5.12. INDEMNIFICATION, DIRECTORS' AND OFFICERS' INSURANCE...........29
SECTION 5.13. STATE TAKEOVER LAWS...........................................30
SECTION 5.14. EMPLOYEE BENEFITS.............................................30
ARTICLE 6 DISSENTING SHARES; EXCHANGE OF SHARES.........................30
SECTION 6.1. DISSENTING SHARES.............................................30
ARTICLE 7 CONDITIONS TO THE OFFER.......................................30
SECTION 7.1. CONDITIONS TO THE OFFER.......................................30
ARTICLE 8 CONDITIONS TO CONSUMMATION OF THE MERGER......................33
SECTION 8.1. CONDITIONS TO EACH PARTY'S OBLIGATIONS TO EFFECT THE MERGER...33
ARTICLE 9 TERMINATION; AMENDMENT; WAIVER................................34
SECTION 9.1. TERMINATION...................................................34
SECTION 9.2. PROCEDURE AND EFFECT OF TERMINATION...........................36
SECTION 9.3. FEES AND EXPENSES.............................................36
SECTION 9.4. AMENDMENT.....................................................37
SECTION 9.5. WAIVER........................................................37
ARTICLE 10 MISCELLANEOUS.................................................37
SECTION 10.1. NONSURVIVAL OF REPRESENTATIONS AND WARRANTIES.................37
SECTION 10.2. ENTIRE AGREEMENT; ASSIGNMENT..................................37
SECTION 10.3. VALIDITY......................................................37
SECTION 10.4. NOTICES.......................................................37
SECTION 10.5. GOVERNING LAW.................................................38
SECTION 10.6. DESCRIPTIVE HEADINGS..........................................38
SECTION 10.7. PARTIES IN INTEREST...........................................39
SECTION 10.8. CERTAIN DEFINITIONS...........................................39
SECTION 10.9. PERSONAL LIABILITY............................................39
SECTION 10.10. SPECIFIC PERFORMANCE..........................................39
SECTION 10.11. COUNTERPARTS..................................................39
ii
<PAGE>
TABLE OF DEFINED TERMS
Term Page
- ---- ----
Acquiring Person .......................................................... 19
Acquisition ............................................................... 1
Acquisition Proposal ...................................................... 24
Affiliate ................................................................. 37
Agreement ................................................................. 1
Blue Sky Laws ............................................................. 11
Board ..................................................................... 1
Break-Up Fee .............................................................. 34
Business Day .............................................................. 37
Cash Merger Consideration ................................................. 6
Certificates .............................................................. 7
Closing Time .............................................................. 5
Company ................................................................... 1
Company Disclosure Schedule ............................................... 8
Company Employee Plan ..................................................... 13
Company Employee Plans .................................................... 13
Company Option Plan ....................................................... 8
Company Option Plans ...................................................... 8
Company Personnel ......................................................... 13
Company Real Assets ....................................................... 16
Company SEC Reports ....................................................... 10
Company Securities ........................................................ 9
Company Stock Option ...................................................... 8
Company Stock Options ..................................................... 8
Confidentiality Agreement ................................................. 26
Continuing Directors ...................................................... 5
Contracts ................................................................. 17
Cure Time ................................................................. 32
DGCL ...................................................................... 3
Disclosure Statement ...................................................... 11
Dissenting Shares ......................................................... 29
Distribution Date ......................................................... 3
Effective Time ............................................................ 5
Environmental Claim ....................................................... 15
Environmental Laws ........................................................ 14
ERISA ..................................................................... 13
Exchange Act .............................................................. 1
Expiration Date ........................................................... 19
Governmental Entity ....................................................... 11
GP ........................................................................ 1
HSR Act ................................................................... 11
Indemnified Parties ....................................................... 28
Intangible Property ....................................................... 19
Knowledge ................................................................. 12
Lien ...................................................................... 9
Material Adverse Effect ................................................... 9
Material Change ........................................................... 29
Merger .................................................................... 5
Merger Certificate ........................................................ 5
Merger Fund ............................................................... 7
iii
<PAGE>
Minimum Stock Condition ................................................... 2
Offer ..................................................................... 1
Offer Documents ........................................................... 2
Parent .................................................................... 1
Parent Material Adverse Effect ............................................ 20
Payment Agent ............................................................. 6
Per Share Amount .......................................................... 1
Permitted Liens ........................................................... 16
Person .................................................................... 37
Right ..................................................................... 6
Rights .................................................................... 6
Rights Agreement .......................................................... 6
Schedule 14D-9 ............................................................ 3
SEC ....................................................................... 2
Section 203 Approval ...................................................... 3
Securities Act ............................................................ 10
Share ..................................................................... 1
Shares .................................................................... 1
Stock ..................................................................... 37
Stockholders Agreement .................................................... 5
Stockholders' Meeting ..................................................... 24
Subsidiaries .............................................................. 37
Subsidiary ................................................................ 37
Superior Proposal ......................................................... 25
Surviving Corporation ..................................................... 5
Tax ....................................................................... 15
Tax Return ................................................................ 15
Taxes ..................................................................... 15
Tender Offer Purchase Time ................................................ 4
iv
<PAGE>
MERGER AGREEMENT
THIS MERGER AGREEMENT (this "Agreement") dated as of June 10, 1999, is
among STERIGENICS INTERNATIONAL, INC., a Delaware corporation ("Company"), ION
BEAM APPLICATIONS S.A., a Belgian corporation ("Parent"), ION BEAM APPLICATIONS
G.P. a general partnership organized under the laws of Delaware which is
controlled by Parent ("GP") and IBA ACQUISITION CORP., a Delaware corporation
which is wholly-owned by GP ("Acquisition").
WHEREAS, the Board of Directors of the Company (the "Board") has, in light
of and subject to the terms and conditions set forth herein, (i) determined that
each of the Offer and the Merger (each as defined below) is advisable on
substantially the terms and conditions set forth herein and is fair to the
stockholders of the Company and in the best interests of such stockholders and
(ii) approved and adopted this Agreement and the transactions contemplated
hereby and resolved, subject to the terms hereof, to recommend acceptance of the
Offer and approval and adoption by the stockholders of the Company, if
necessary, of this Agreement; and
WHEREAS, in furtherance thereof, it is proposed that Acquisition shall,
within five (5) business days after the public announcement hereof, commence a
tender offer (the "Offer") to acquire all of the issued and outstanding Shares
(defined herein) together with the associated Rights (defined herein) which are
not owned by Parent, GP, or Acquisition or any affiliate thereof, at a price of
$27.00 per Share (subject to adjustment for stock splits, stock dividends,
combinations, recapitalizations or the like) (such amount, being hereinafter
referred to as the "Per Share Amount"), net to the seller in cash, less any
required withholding of taxes, in accordance with the terms and subject to the
conditions provided herein;
NOW THEREFORE, in consideration of the premises and the representations,
warranties, covenants and agreements herein contained and intending to be
legally bound hereby, the Company, Parent, GP, and Acquisition hereby agree as
follows:
ARTICLE 1
THE OFFER
SECTION 1.1. The Offer. (a) Provided that this Agreement shall not have
been terminated in accordance with Section 9.1, as promptly as possible but in
no event later than five (5) business days after the public announcement of the
execution hereof by the parties, Parent and GP shall cause Acquisition to
commence (within the meaning of Rule 14d-2 under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), the Offer; and to cause Acquisition to
use its best efforts to consummate the Offer, including, without limitation,
engaging an information agent in connection therewith. Acquisition shall accept
for payment issued and outstanding shares of common stock, $0.001 par value of
the Company (individually a "Share" and collectively, the "Shares") together
with the associated Rights which have been validly tendered and not withdrawn
pursuant to the Offer at the earliest time following expiration of the Offer
that all conditions to the Offer shall have been satisfied or waived by
Acquisition. The
<PAGE>
obligation of Acquisition to accept for payment, purchase and pay for Shares
tendered pursuant to the Offer shall be subject to the condition that the number
of Shares validly tendered and not withdrawn prior to the expiration of the
Offer, combined with the Shares already owned by Parent, GP, Acquisition or any
of their affiliates, constitutes at least a majority of the then outstanding
Shares on a fully-diluted basis (including for purposes of such calculation all
Shares issuable upon exercise of all vested and unvested stock options, and
conversion of convertible securities or other rights to purchase or acquire
Shares) at the expiration of the Offer (the "Minimum Stock Condition") and the
other conditions set forth in Article 7. Acquisition expressly reserves the
right to waive any such condition, to increase the Per Share Amount, and to make
any other changes in the terms and conditions of the Offer; provided, however,
that Parent, GP and Acquisition agree that no change may be made without the
written consent of the Company which decreases the Per Share Amount, which
changes the form of consideration to be paid in the Offer, which reduces the
maximum number of shares to be purchased in the Offer, which reduces the Minimum
Stock Condition to below a majority of the then outstanding shares (on a
fully-diluted basis), which otherwise modifies or amends the conditions to the
Offer or any other term of the Offer in a manner that is materially adverse to
the holders of the Shares, which imposes conditions to the Offer in addition to
those set forth in Article 7 or which extends the expiration date of the Offer
beyond September 30, 1999 (except that Acquisition may extend the expiration
date of the Offer beyond September 30, 1999 as required to comply with any rule,
regulation or interpretation of the Securities and Exchange Commission or to
provide the time necessary to satisfy the conditions set forth in Article 7). It
is agreed that the conditions set forth in Article 7 are for the sole benefit of
Acquisition and may be asserted by Acquisition regardless of the circumstances
giving rise to any such condition (including any action or inaction by
Acquisition) or may be waived by Acquisition, in whole or in part at any time
and from time to time, in its sole discretion. The failure by Acquisition at any
time to exercise any of the foregoing rights shall not be deemed a waiver of any
such right and each such right shall be deemed an ongoing right which may be
asserted at any time and from time to time. The Per Share Amount shall be paid
net to the seller in cash, less any required withholding of taxes, upon the
terms and subject to such conditions of the Offer. The Company agrees that no
Shares held by the Company or any of its subsidiaries will be tendered in the
Offer.
(b) As soon as practicable after the date hereof, Parent, GP and
Acquisition agree that Parent, GP and Acquisition shall file with the Securities
and Exchange Commission (the "SEC") a Tender Offer Statement on Schedule 14D-1
with respect to the Offer, which shall include an offer to purchase and form of
transmittal letter (together with any amendments thereof or supplements thereto,
collectively the "Offer Documents"). The Company and its counsel shall be given
a reasonable opportunity to review and comment on the Offer Documents prior to
their filing with the SEC or dissemination to the stockholders of the Company.
Parent and Acquisition agree to provide the Company and its counsel with any
comments which Parent, Acquisition or their counsel may receive from the SEC or
the staff of the SEC with respect to such documents promptly after receipt
thereof. The Offer Documents will comply in all material respects with the
provisions of applicable federal securities laws. The information provided and
to be provided by Parent, GP and Acquisition for use in the Offer Documents
shall not, on the date filed with the SEC and on the date first published or
sent or given to the Company's stockholders, as the case may be, contain any
untrue statement of a material fact nor omit to state any material fact required
to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading, provided,
however, that no representation or warranty is made by Parent, GP or Acquisition
with respect to information supplied by the Company or any of its stockholders
for inclusion in the Offer Documents. The Company agrees that information
provided by the Company or any of its subsidiaries for inclusion or
2
<PAGE>
incorporation in the Offer Documents shall not, on the date filed with the SEC
and on the date first published or sent or given to the Company's stockholders,
as the case may be, contain any untrue statement of a material fact nor omit to
state any material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they were
made, not misleading. Parent, GP, Acquisition and the Company each agree
promptly to correct any information provided by it for use in the Offer
Documents if and to the extent that such information shall have become false or
misleading in any material respect and Parent, GP and Acquisition further agree
to take all steps necessary to cause the Offer Documents as so corrected to be
filed with the SEC and to be disseminated to holders of Shares, in each case as
and to the extent required by applicable federal securities laws.
SECTION 1.2. Company Action. (a) The Company hereby approves of and
consents to the Offer and the Merger and represents and warrants that (i) the
Board has, subject to the terms and conditions set forth herein, adopted final
and binding resolutions, which have not been amended or repealed, pursuant to
which the Board (A) determined that this Agreement, and the transactions
contemplated hereby and thereby, including the Offer and the Merger, are fair
to, and in the best interests of, the stockholders of the Company, (B) approved
and adopted this Agreement, and the Stockholders Agreement (defined herein) and
the transactions contemplated hereby and thereby, including without limitation,
the Merger and the acquisition of Shares by Parent or Acquisition pursuant to
the options granted by the Stockholders under the Stockholders Agreement, and
such approval (the "Section 203 Approval") constitutes the approval of the
foregoing for the purposes of Section 203 of the Delaware General Corporation
Law ("DGCL"), (C) taken all necessary action to avoid the occurrence of a
"Distribution Date" (as defined in the Rights Agreement referred to in Section
2.8) with respect to the Rights, and (D) recommended that the stockholders of
the Company accept the Offer, tender their Shares thereunder to Acquisition and,
if required by law, approve and adopt this Agreement and the Merger (provided,
however, that subject to the provisions of Section 5.3 such recommendation may
be withdrawn, modified or amended in connection with a Superior Proposal (as
defined in Section 5.3)) and (ii) PaineWebber Incorporated and TM Capital Corp.
have each delivered to the Board a written opinion to the effect that, as of the
date of such opinion, the consideration to be received by the holders of the
Shares (other than the Parent, GP, Acquisition and their affiliates) pursuant to
the Offer and Merger is fair to such holders from a financial point of view.
Subject only to the provisions of Section 5.3, the Company hereby consents to
the inclusion in the Offer Documents of the recommendation of the Board
described in the immediately preceding sentence.
(b) The Company hereby agrees to file with the SEC as soon as practicable
after the date hereof a Solicitation/Recommendation Statement on Schedule 14D-9
pertaining to the Offer (together with any amendments thereof or supplements
thereto, the "Schedule 14D-9") containing the recommendation described in
Section 1.2(a) and to promptly mail the Schedule 14D-9 to the stockholders of
the Company. The Company represents and warrants that the Schedule 14D-9 will
comply in all material respects with the provisions of applicable federal
securities laws and, on the date filed with the SEC and on the date first
published or sent or given to the Company's stockholders, as the case may be,
shall not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading, except that no representation is made by the Company with
respect to information supplied by Parent, GP or Acquisition in writing for
inclusion in the Schedule 14D-9. The Company, Parent, GP and Acquisition each
agrees promptly to correct any information provided by it for use in the
Schedule 14D-9 if and to the extent that such information shall have become
3
<PAGE>
false or misleading in any material respect and the Company further agrees to
take all steps necessary to cause the Schedule 14D-9 as so corrected to be filed
with the SEC and disseminated to the holders of Shares, in each case as and to
the extent required by applicable federal securities laws.
(c) In connection with the Offer, the Company will promptly furnish Parent
and Acquisition with mailing labels, security position listings and any
available listing or computer files containing the names and addresses of the
record holders of the Shares as of a recent date and shall furnish Acquisition
with such additional information and assistance (including, without limitation,
updated lists of stockholders, mailing labels and lists of securities positions)
as Acquisition or its agents may reasonably request in communicating the Offer
to the record and beneficial holders of Shares. Subject to the requirements of
applicable law, and except for such steps as are necessary to disseminate the
Offer Documents and any other documents necessary to consummate the Merger,
Parent, GP, Acquisition and their affiliates, associates, agents and advisors
shall hold in confidence the information contained in any of such labels and
lists, and use the information contained in any such labels, listings and files
only in connection with the Offer and the Merger, and, if this Agreement shall
be terminated, will deliver to the Company all copies of such information then
in their possession.
SECTION 1.3. Boards of Directors and Committees; Section 14(f). (a)
Promptly upon the purchase by Acquisition of Shares following the expiration
date (as such date may be extended) of, and pursuant to, the Offer (the "Tender
Offer Purchase Time") and from time to time thereafter, and subject to the last
sentence of this Section 1.3(a), Acquisition shall be entitled to designate
directors of the Company constituting a majority of the Board, and the Company
shall use its best efforts to, upon request by Acquisition, promptly, at the
Company's election, either increase the size of the Board to the extent
permitted by its Certificate of Incorporation or secure the resignation of such
number of directors as is necessary to enable Acquisition's designees to be
elected to the Board and to cause Acquisition's designees to be so elected and
to constitute at all times after the Tender Offer Purchase Time a majority of
the Board. At such times, and subject to the last sentence of this Section
1.3(a), the Company will use its best efforts to cause persons designated by
Acquisition to constitute the same percentage as is on the Board of (i) each
committee of the Board (other than any committee of the Board established to
take action under this Agreement), (ii) each board of directors of each
subsidiary of the Company and (iii) each committee of each such board.
Notwithstanding the foregoing, the Company shall use reasonable efforts to
encourage James F. Clouser and Fred Ruegsegger to remain members of the Board
until the Effective Time (as determined herein).
(b) The Company's obligation to appoint designees to the Board shall be
subject to Section 14(f) of the Exchange Act and Rule 14f-1 promulgated
thereunder. The Company shall promptly take all action required pursuant to such
Section and Rule in order to fulfill its obligations under this Section 1.3 and
shall include in the Schedule 14D-9 such information with respect to the Company
and its officers and directors as is required under such Section and Rule in
order to fulfill its obligations under this Section 1.3. Acquisition will supply
to the Company in writing and be solely responsible for any information with
respect to itself and its nominees, officers, directors and affiliates required
by such Section and Rule.
(c) Following the election or appointment of Acquisition's designees
pursuant to this Section 1.3 and prior to the Effective Time, any amendment or
termination of this Agreement, extension of the performance or waiver of the
obligations
4
<PAGE>
or other acts of Parent, GP or Acquisition or waiver of the Company's rights
hereunder, shall require the concurrence of a majority of the Company's
directors (or the concurrence of the director, if there is only one remaining)
then in office who are directors on the date hereof, or are directors (other
than directors designated by Acquisition in accordance with this Section 1.3)
designated by such persons to fill any vacancy (the "Continuing Directors").
SECTION 1.4. Stockholders Agreement. In order to induce Parent, GP and
Acquisition to enter into this Agreement and to perform their obligations
hereunder and as a condition thereof, Parent, GP and Acquisition shall enter
into the stockholders agreement (the "Stockholders Agreement") on even date
hereof in the form attached hereto as Exhibit A stockholders of the Company
listed in Schedule A to the Stockholders Agreement.
ARTICLE 2
THE MERGER
SECTION 2.1. The Merger. At the Effective Time (as defined below) and upon
the terms and subject to the conditions of this Agreement and in accordance with
the DGCL, Acquisition shall be merged with and into the Company (the "Merger").
Following the Merger, the Company shall continue as the surviving corporation
(the "Surviving Corporation") and the separate corporate existence of
Acquisition shall cease. GP, as the sole stockholder of Acquisition, hereby
approves this Agreement, the Merger and the other transactions contemplated
hereby.
SECTION 2.2. Closing of the Merger. The closing of the Merger will take
place at a time (the "Closing Time") and on a date to be specified by the
parties, which shall be no later than the second business day after satisfaction
of the latest to occur of the conditions set forth in Article 8 at the offices
of Dorsey & Whitney LLP, 250 Park Avenue, New York, New York 10177, unless
another time, date or place is agreed to in writing by the parties hereto.
SECTION 2.3. Effective Time. Subject to the terms and conditions set forth
in this Agreement, a certificate of merger (the "Merger Certificate") shall be
duly executed and acknowledged by Acquisition and the Company and thereafter
delivered at the Closing Time to the Secretary of State of the State of Delaware
for filing pursuant to the DGCL. The Merger shall become effective at such time
as a properly executed and certified copy of the Merger Certificate is duly
accepted for record by the Secretary of State of the State of Delaware for
filing pursuant to the DGCL, or such later time as Acquisition and the Company
may agree upon and set forth in the Merger Certificate (not exceeding 30 days
after the Merger Certificate is accepted for record; the time the Merger becomes
effective being referred to herein as the "Effective Time").
SECTION 2.4. Effects of the Merger. The Merger shall have the effects set
forth in the DGCL. Without limiting the generality of the foregoing and subject
thereto at the Effective Time, all the properties, rights, privileges, powers
and franchises of the Company and Acquisition shall vest in the Surviving
Corporation and all debts, liabilities and duties of the Company and Acquisition
shall become the debts, liabilities and duties of the Surviving Corporation.
SECTION 2.5. Charter and Bylaws. The Certificate of Incorporation of the
Company in effect at the Effective Time shall be the Certificate of
Incorporation of the
5
<PAGE>
Surviving Corporation until amended in accordance with applicable law. The
Bylaws of the Company in effect at the Effective Time shall be the Bylaws of the
Surviving Corporation until amended in accordance with applicable law.
SECTION 2.6. Directors. The directors of Acquisition at the Effective Time
shall be the initial directors of the Surviving Corporation, each to hold office
in accordance with the charter and Bylaws of the Surviving Corporation until the
next annual meeting of stockholders and until each such director's successor is
duly elected or appointed and qualified.
SECTION 2.7. Officers. The officers of Acquisition at the Effective Time
shall be the initial officers of the Surviving Corporation, each to hold office
in accordance with the charter and Bylaws of the Surviving Corporation until
such officer's successor is duly elected or appointed and qualified.
SECTION 2.8. Conversion of Shares.
(a) At the Effective Time, each Share issued and outstanding immediately
prior to the Effective Time, together with the associated right to purchase
shares of Series A Junior Participating Preferred Stock, par value $0.001 per
share (individually, the "Right" and collectively, the "Rights"), issued
pursuant to the Rights Agreement dated as of March 31, 1999 between the Company
and US Stock Transfer Corporation, as Rights Agent (the "Rights Agreement"
(other than (i) Shares together with any associated Rights held by any of the
Company's subsidiaries, (ii) Shares together with any associated Rights held by
Parent, GP, Acquisition or any other subsidiary of Parent and (iii) Dissenting
Shares (defined herein)) shall, by virtue of the Merger and without any action
on the part of Acquisition, the Company or the holder thereof, be converted into
and shall become the right to receive the Per Share Amount in cash, without
interest (the "Cash Merger Consideration"). Notwithstanding the foregoing, if
between the date of this Agreement and the Effective Time, the Shares shall have
been changed into a different number of shares or a different class by reason of
any stock dividend, subdivision, reclassification, recapitalization, split,
combination or exchange of shares, then the Cash Merger Consideration
contemplated by the Merger shall be correspondingly adjusted to reflect such
stock dividend, subdivision, reclassification, recapitalization, split,
combination or exchange of shares.
(b) At the Effective Time, each Share, together with any associated Right,
then owned by Parent, GP, Acquisition, the Company or any direct or indirect
wholly-owned subsidiary of Parent, GP or Acquisition or of the Company shall, by
virtue of the Merger and without any action on the part of Parent, GP,
Acquisition, the Company or the holder thereof, be canceled and retired and will
cease to exist and no payment shall be made with respect thereto.
(c) At the Effective Time, each share of common stock of Acquisition issued
and outstanding immediately prior to the Effective Time shall be converted into
and exchanged for one fully-paid and non-assessable share of common stock, par
value $0.001 per share of the Surviving Corporation.
SECTION 2.9. Payment of Cash Merger Consideration.
(a) As of the Effective Time, Acquisition shall deposit with such agent or
agents as may be appointed by Parent and Acquisition (the "Payment Agent") for
the benefit of the holders of Shares in cash the aggregate amount necessary to
pay the Cash
6
<PAGE>
Merger Consideration (such cash is hereinafter referred to as the "Merger Fund")
payable pursuant to Section 2.8 in exchange for outstanding Shares.
(b) As soon as reasonably practicable after the Effective Time, the Payment
Agent shall mail to each holder of record of a certificate or certificates which
immediately prior to the Effective Time represented outstanding Shares (the
"Certificates") whose shares were converted into the right to receive the Cash
Merger Consideration pursuant to Section 2.8: (i) a letter of transmittal (which
shall specify that delivery shall be effected and risk of loss and title to the
Certificates shall pass only upon delivery of the Certificates to the Payment
Agent and shall be in such form and have such other provisions as Parent and the
Company may reasonably specify) and (ii) instructions on how to surrender the
Certificates in exchange for the Cash Merger Consideration. Upon surrender to
the Payment Agent of a Certificate for cancellation, together with such letter
of transmittal duly executed, the holder of such Certificate shall be entitled
to receive in exchange therefor a check representing the Cash Merger
Consideration which such holder has the right to receive pursuant to the
provisions of this Article 2 and the Certificate so surrendered shall forthwith
be canceled. In the event of a transfer of ownership of Shares which is not
registered in the transfer records of the Company, payment of the Cash Merger
Consideration may be made to a transferee if the Certificate representing such
Shares is presented to the Payment Agent accompanied by all documents required
to evidence and effect such transfer and by evidence that any applicable stock
transfer taxes have been paid. Until surrendered as contemplated by this Section
2.9, each Certificate shall be deemed at any time after the Effective Time to
represent only the right to receive upon such surrender the Cash Merger
Consideration as contemplated by this Section 2.9.
(c) In the event that any Certificate shall have been lost, stolen or
destroyed, the Payment Agent shall issue in exchange therefor, upon the making
of an affidavit of that fact by the holder thereof, such Cash Merger
Consideration as may be required pursuant to this Agreement; provided, however,
that Acquisition or its Payment Agent may, in its discretion, require the
delivery of a suitable bond or indemnity.
(d) All Cash Merger Consideration paid upon the surrender for exchange of
Shares in accordance with the terms hereof shall be deemed to have been paid in
full satisfaction of all rights pertaining to such Shares; subject, however, to
the Surviving Corporation's obligation to pay any dividends or make any other
distributions with a record date prior to the Effective Time which may have been
declared or made by the Company on such Shares in accordance with the terms of
this Agreement, or prior to the date hereof and which remain unpaid at the
Effective Time, and there shall be no further registration of transfers on the
stock transfer books of the Surviving Corporation of the Shares which were
outstanding immediately prior to the Effective Time. If after the Effective Time
Certificates are presented to the Surviving Corporation for any reason they
shall be canceled and exchanged as provided in this Article 2.
(e) Any portion of the Merger Fund which remains undistributed to the
stockholders of the Company for six months after the Effective Time shall be
delivered to Parent upon demand and any stockholders of the Company who have not
theretofore complied with this Article 2 shall thereafter look only to Parent
for payment of their claim for the Cash Merger Consideration.
(f) Neither Acquisition nor the Company shall be liable to any holder of
Shares for cash from the Merger Fund delivered to a public official pursuant to
any applicable abandoned property, escheat or similar law.
7
<PAGE>
SECTION 2.10. Stock Options; Purchase Plan.
(a) At the Effective Time, each outstanding option to purchase Shares (a
"Company Stock Option" or collectively "Company Stock Options") issued pursuant
to the Company's 1997 Equity Incentive Plan and its Second Amended and Restated
1986 Stock Option Plan (a "Company Option Plan" or collectively "Company Option
Plans") shall vest in full and the Surviving Corporation shall pay to the holder
of each outstanding Company Stock Option an amount equal to the excess, if any,
of the Per Share Amount over the exercise price per Share of such Company Stock
Option, less the amount of Taxes (defined below) required to be withheld under
Federal, state or local laws and regulations multiplied by the number of Shares
subject to such Company Stock Option. To the extent required the Company will
take all reasonable steps to effectuate the foregoing provisions of this Section
2.10.
(b) Except as provided herein or as otherwise agreed to by the parties and
to the extent permitted by the Company Option Plan, the Company Option Plans
shall terminate as of the Effective Time and any rights under any provisions
under the Company Option Plans and any awards issued thereunder shall be
canceled as of the Effective Time.
(c) The Company shall amend the 1997 Employee Stock Purchase Plan to
provide for (A) the suspension of participation during the offering periods
commencing subsequent to the date of the Agreement for the pendency of the
Merger and subject to the successful consummation of the Merger and (B) the
termination of such Plan as of the Effective Time.
ARTICLE 3
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Except as set forth on the Disclosure Schedule previously delivered by the
Company to Parent (the "Company Disclosure Schedule"), the Company hereby
represents and warrants to each of Parent, GP and Acquisition as follows:
SECTION 3.1. Organization and Qualification; Subsidiaries.
(a) Section 3.1 of the Company Disclosure Schedule identifies each
subsidiary of the Company as of the date hereof and its respective jurisdiction
of incorporation or organization, as the case may be. The Company and each of
its subsidiaries is duly organized, validly existing and in good standing under
the laws of the jurisdiction of its incorporation or organization as set forth
in Section 3.1 of the Company Disclosure Schedule and has all requisite power
and authority to own lease and operate its properties and to carry on its
businesses as now being conducted, except where such failure to so qualify would
not have a Material Adverse Effect (defined herein) on the Company. The Company
has heretofore provided Parent with access to accurate and complete copies of
the charter and Bylaws (or similar governing documents), as currently in effect,
of the Company and its subsidiaries.
(b) Except as disclosed in Section 3.1(b) of the Company Disclosure
Schedule, each of the Company and its subsidiaries is duly qualified or licensed
and in good standing to do business in each jurisdiction in which the property
owned, leased or operated by it or the nature of the business conducted by it
makes such qualification or licensing necessary, except in such jurisdictions
where the failure to be so duly qualified or licensed and in good standing would
not have a Material Adverse Effect on the Company.
8
<PAGE>
When used in connection with the Company or its subsidiaries, the term "Material
Adverse Effect" means any change or effect (i) that is materially adverse to the
business, properties, financial condition or results of operations of the
Company and its subsidiaries, taken as whole, or (ii) that would materially
impair the ability of the Company to consummate the transactions contemplated
hereby.
SECTION 3.2. Capitalization of the Company and its Subsidiaries.
(a) As of the date hereof, the authorized stock of the Company consists of
15,000,000 Shares, of which, as of May 31, 1999, 8,005,802 Shares were issued
and outstanding, and 1,000,000 shares of preferred stock, par value $0.001 per
share, no shares of which are outstanding. All of the outstanding Shares have
been validly issued and are fully paid, nonassessable and free of preemptive
rights. As of May 31, 1999, approximately 1,182,210 Shares were reserved for
issuance and issuable upon or otherwise deliverable in connection with the
exercise of outstanding Company Stock Options issued pursuant to the Company
Option Plans referred to in Section 2.10. Between May 31, 1999 and the date
hereof, no shares of the Company's stock have been issued other than pursuant to
Company Stock Options, and between May 31, 1999 and the date hereof no stock
options have been granted. Except as set forth above and in Section 3.2(a) of
the Company Disclosure Schedule, as of the date hereof, there are issued,
reserved for issuance, or outstanding (i) no shares of stock or other voting
securities of the Company, (ii) no securities of the Company or its subsidiaries
convertible into or exchangeable for shares of stock or voting securities of the
Company, (iii) no options or other rights to acquire from the Company or its
subsidiaries and, except as described in the Company SEC Reports (defined
herein), no obligations of the Company or its subsidiaries to issue any stock,
voting securities or securities convertible into or exchangeable for stock or
voting securities of the Company, (iv) no bonds, debentures, notes or other
indebtedness or obligations of the Company or any of its subsidiaries entitling
the holders thereof to have the right to vote (or which are convertible into, or
exercisable or exchangeable for, securities entitling the holders thereof to
have the right to vote) with the stockholders of the Company or any of its
subsidiaries on any matter, (v) no equity equivalent interests in the ownership
or earnings of the Company or its subsidiaries or other similar rights, and (vi)
the Rights (collectively "Company Securities"). As of the date hereof, there are
no outstanding obligations of the Company or its subsidiaries (absolute,
contingent or otherwise) to repurchase, redeem or otherwise acquire any Company
Securities. There are no Shares outstanding subject to rights of first refusal
of the Company, nor are there any pre-emptive rights with respect to any Shares.
Other than this Agreement, there are no stockholder agreements, voting trusts or
other agreements or understandings to which the Company is a party or by which
it is bound relating to the voting or registration of any shares of stock of the
Company.
(b) Except as disclosed in Section 3.2(b) of the Company Disclosure
Schedule, all of the outstanding stock of the Company's subsidiaries is owned by
the Company, directly or indirectly, free and clear of any Lien (defined herein)
or any other limitation or restriction (including any restriction on the right
to vote or sell the same except as may be provided as a matter of law). There
are no securities of the Company or its subsidiaries convertible into or
exchangeable for, no options or other rights to acquire from the Company or its
subsidiaries and no other contract, understanding, arrangement or obligation
(whether or not contingent) providing for, the issuance or sale, directly or
indirectly, of any stock or other ownership interests in, or any other
securities of any subsidiary of, the Company. There are no outstanding
contractual obligations of the Company or its subsidiaries to repurchase, redeem
or otherwise acquire any outstanding shares of capital stock or other ownership
interests in any subsidiary of the Company. For purposes of this Agreement,
"Lien" means, with respect to any asset (including without
9
<PAGE>
limitation any security), any mortgage, lien, pledge, charge, security interest
or encumbrance of any kind in respect of such asset.
(c) The Shares and the Rights constitute the only classes of equity
securities of the Company or its subsidiaries registered or required to be
registered under the Exchange Act.
SECTION 3.3. Authority Relative to this Agreement; Recommendation.
The Company has all necessary corporate power and authority to execute and
deliver this Agreement and, if required by law, subject to stockholder approval
of the Merger, to consummate the transactions contemplated hereby. The execution
and delivery of this Agreement and the consummation of the transactions
contemplated hereby have been duly and validly authorized by the Board and no
other corporate proceedings on the part of the Company are necessary to
authorize this Agreement or to consummate the transactions contemplated hereby
except, if required by law, the approval and adoption of this Agreement and the
Merger by the holders of the outstanding Shares. This Agreement has been duly
and validly executed and delivered by the Company and assuming the due
authorization, execution and delivery by Parent, GP and Acquisition, constitutes
a valid, legal and binding agreement of the Company enforceable against the
Company in accordance with its terms, except as such enforceability may be
limited by any applicable bankruptcy, insolvency, reorganization, moratorium or
other similar laws affecting the enforcement of creditors' rights generally, and
except as the availability of equitable remedies may be limited by the
application of general principles of equity (regardless of whether such
equitable principle is applied in a proceeding at law or in equity).
The Board has duly and validly approved, and taken all corporate actions
required to be taken by the Board for the consummation of, the transactions
contemplated hereby, including the Offer and the acquisition of the Shares
pursuant thereto and the Merger. The Board has taken all appropriate action so
that none of Parent, GP or Acquisition will be an "interested stockholder"
within the meaning of Section 203 of the DGCL by virtue of Parent, GP,
Acquisition and the Company entering into this Agreement, or the Stockholders
Agreement or any other agreement contemplated hereby or thereby and consummating
the transactions contemplated hereby and thereby.
SECTION 3.4. SEC Reports; Financial Statements.
(a) The Company has filed all required forms, reports and documents
("Company SEC Reports") with the SEC since its initial public offering on August
13, 1997, each of which has complied in all material respects with all
applicable requirements of the Securities Act of 1933, as amended (the
"Securities Act"), and the Exchange Act, each as in effect on the dates such
forms, reports and documents were filed. None of such Company SEC Reports,
including, without limitation, any financial statements or schedules included or
incorporated by reference therein, contained when filed any untrue statement of
a material fact or omitted to state a material fact required to be stated or
incorporated by reference therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. The audited consolidated financial statements of the Company
included in the Company SEC Reports fairly present in conformity with GAAP
(except as may be indicated in the notes thereto or, in the case of unaudited
consolidated quarterly statements, as permitted by Form 10-Q of the SEC) the
consolidated financial position of the Company and its consolidated subsidiaries
as of the dates thereof and their consolidated results of operations and changes
in financial position for the periods then ended.
10
<PAGE>
(b) The Company has heretofore made available or promptly will make
available to Acquisition or Parent a complete and correct copy of any amendments
or modifications which are required to be filed with the SEC but have not yet
been filed with the SEC to agreements, documents or other instruments which
previously had been filed by the Company with the SEC pursuant to the Exchange
Act.
SECTION 3.5. Information Supplied. Neither the Schedule 14D-9 nor any of
the information supplied or to be supplied by the Company for inclusion or
incorporation by reference in the Offer Documents, Schedule 14D-9, any other
tender offer materials, Schedule 14A or 14C, or the proxy statement or
information statement ("Proxy Statement") relating to any meeting of the
Company's stockholders to be held in connection with the Merger (all of the
foregoing documents, collectively, the "Disclosure Statements") will, at the
date each and any of the Disclosure Statements is filed with the SEC or are
first published, mailed to stockholders of the Company, and at the time of the
meeting of stockholders of the Company to be held, if necessary, in connection
with the Merger (the "Stockholders' Meeting" (defined herein)) contain any
untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they are made, not misleading; provided,
however, that no representation or warranty is made by the Company with respect
to information supplied by Parent, Acquisition or GP, for inclusion in the
Disclosure Statements. The Disclosure Statements will comply as to form in all
material respects with all provisions of applicable law.
SECTION 3.6. Consents and Approvals; No Violations. Except for filings,
permits, authorizations, consents and approvals as may be required under, and
other applicable requirements of, the Exchange Act, state securities laws ("Blue
Sky Laws"), the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended
(the "HSR Act"), and the securities or antitrust laws of any foreign country,
and the filing and recordation and acceptance for record of the Merger
Certificate as required by the DGCL, respectively, no filing with or notice to
and no permit, authorization, consent or approval of any court or tribunal, or
administrative governmental or regulatory body, agency or authority (a
"Governmental Entity") is necessary for the execution and delivery by the
Company of this Agreement or the consummation by the Company of the transactions
contemplated hereby, except where the failure to obtain such permits,
authorizations, consents or approvals or to make such filings or give such
notice would not have a Material Adverse Effect. Neither the execution, delivery
and performance of this Agreement by the Company nor the consummation by the
Company of the transactions contemplated hereby will (i) conflict with or result
in any breach of any provision of the respective charter or Bylaws (or similar
governing documents) of the Company or any of its subsidiaries, (ii) result in a
violation or breach of or constitute (with or without due notice or lapse of
time or both) a default (or give rise to any right of termination, amendment,
cancellation or acceleration or Lien) under any of the terms, conditions or
provisions of any note, bond, mortgage, indenture, lease, license, contract,
agreement or other instrument or obligation to which the Company or any of its
subsidiaries is a party or by which any of them or any of their respective
properties or assets may be bound or (iii) conflict with or violate any order,
writ, injunction, decree, law, statute, rule or regulation applicable to the
Company or any of its subsidiaries or any of their respective properties or
assets except, in the case of (ii) or (iii), for violations, breaches or
defaults which would not have a Material Adverse Effect.
SECTION 3.7. Compliance with Applicable Law. Neither the Company nor any of
its subsidiaries is in conflict with, or in default or violation of (a) its
respective charter or certificate of incorporation, bylaws, or other charter or
organization documents, (b) to the Company's Knowledge (defined herein), any
law, statute, rule, regulation, order,
11
<PAGE>
judgment, writ, injunction or decree applicable to the Company or any of its
subsidiaries or any of their respective properties or assets, or (c) any note,
bond, mortgage, indenture, contract, agreement, lease, license, permit,
franchise or other instrument or obligation to which the Company or any of its
subsidiaries is a party or by which the Company or any of its subsidiaries or
any property or asset of the Company or any of its subsidiaries may be bound or
affected, in the case of (b) or (c), the effect of which conflict, default or
violation, either individually or in the aggregate, would be reasonably likely
to be a Material Adverse Effect. To the Company's Knowledge, the Company and its
subsidiaries hold all material licenses, permits, approvals and other
authorizations of Governmental Entities, and are in substantial compliance with
all applicable laws and governmental regulations in connection with their
businesses as now being conducted (except where such non-compliance would not
have a Material Adverse Effect on the Company). For the purposes hereof, the
term "Knowledge" with respect to the Company means the actual knowledge of the
officers and directors of the Company including knowledge obtained in the
ordinary course of the operation of the business of the Company from the
managers of the facilities of the Company.
SECTION 3.8. No Undisclosed Liabilities; Absence of Changes. Except to the
extent publicly disclosed in the Company's SEC Reports or in the Company
Disclosure Schedule, as of December 31, 1998, none of the Company or any of its
subsidiaries had any material liabilities or obligations of any nature, whether
or not accrued, contingent or otherwise, that would be required by GAAP to be
reflected on a consolidated balance sheet of the Company and its subsidiaries
(including the notes thereto) or which would have a Material Adverse Effect on
the Company and since such date, the Company has incurred no such liability or
obligation. Since December 31, 1998, except as disclosed in the Company SEC
Reports, (a) the Company and its subsidiaries have conducted their respective
businesses only in the ordinary course and in a manner consistent with past
practice and (b) there has not been (i) any change, event, occurrence or
circumstance in the business, operations, properties, financial condition or
results of operations of the Company or any of its subsidiaries which,
individually or in the aggregate, has a Material Adverse Effect on the Company
(except for changes, events, occurrences or circumstances (A) with respect to
general economic conditions or (B) arising as a result of the transactions
contemplated hereby), (ii) any material change by the Company in its accounting
methods, principles or practices, (iii) any authorization, declaration, setting
aside or payment of any dividend or distribution or capital return in respect of
any stock of, or other equity interest in, the Company or any of its
subsidiaries, (iv) any material revaluation for financial statement purposes by
the Company or any of its subsidiaries of any asset (including, without
limitation, any writing down of the value of any property, investment or asset
or writing off of notes or accounts receivable), (v) other than payment of
compensation for services rendered to the Company or any of its subsidiaries in
the ordinary course of business consistent with past practice or the grant of
Company Stock Options as described in (and in amounts consistent with) Section
3.2, any material transactions between the Company or any of its subsidiaries,
on the one hand, and any (A) officer or director of the Company or any of its
subsidiaries, (B) record or beneficial owner of five percent (5%) or more of the
voting securities of the Company, or (C) affiliate of any such officer, director
or beneficial owner, on the other hand, or (vi) other than pursuant to the terms
of the plans, programs or arrangements specifically referred to in Section 3.11
or Section 3.11 of the Company Disclosure Schedule or in the ordinary course of
business consistent with past practice, any increase in or establishment of any
bonus, insurance, welfare, severance, deferred compensation, pension,
retirement, profit sharing, stock option (including, without limitation, the
granting of stock options, stock appreciation rights, performance awards or
restricted stock awards), stock purchase or other employee benefit plan, or any
other increase in the compensation payable or to become payable to any
employees, officers, directors or consultants of the Company or
12
<PAGE>
any of its subsidiaries, which increase or establishment, individually or in the
aggregate, will result in a material liability.
SECTION 3.9. Litigation. Except as publicly disclosed in the Company SEC
Reports, there is no suit, claim, action, proceeding or investigation pending
or, to the Company's Knowledge, threatened against the Company or any of its
subsidiaries or any of their respective properties or assets before any
Governmental Entity which individually or in the aggregate could reasonably be
expected to have a Material Adverse Effect on the Company or could reasonably be
expected to prevent or delay the consummation of the transactions contemplated
by this Agreement. Except as publicly disclosed by the Company in the Company
SEC Reports, none of the Company or its subsidiaries nor any property or asset
of the Company or any of its subsidiaries is subject to any outstanding order,
writ, injunction or decree which insofar as can be reasonably foreseen in the
future could reasonably be expected to have a Material Adverse Effect on the
Company or could reasonably be expected to prevent or delay the consummation of
the transactions contemplated hereby.
SECTION 3.10. Year 2000 Compliance. To the Company's Knowledge, the
disclosure contained in the Company's quarterly report on Form 10-Q for the
quarter ended December 31, 1998 does not contain any material misstatement or
omission regarding the status of the Company's Year 2000 readiness.
SECTION 3.11. Employee Benefit Plans; Labor Matters
(a) Section 3.11(a) of the Company Disclosure Schedule sets forth each plan
which is subject to the Employee Retirement Income Security Act of 1974, as
amended ("ERISA"), and each other material agreement, arrangement or commitment
which is an employment or consulting agreement, executive or incentive
compensation plan, bonus plan, deferred compensation agreement, employee
pension, profit sharing, savings or retirement plan, employee stock option or
stock purchase plan, group life, health, or accident insurance or other employee
benefit plan, agreement, arrangement or commitment, including, without
limitation, severance, vacation, holiday or other bonus plans, currently
maintained by the Company or any of its subsidiaries for the benefit of any
present or former employees, officers or directors of the Company or any of its
subsidiaries ("Company Personnel") or with respect to which the Company or any
of its subsidiaries has liability or makes or has an obligation to make
contributions (each such plan, agreement, arrangement or commitment set forth in
Section 3.11(a) of the Company Disclosure Schedule being hereinafter referred to
as a "Company Employee Plan").
(b) With respect to each Company Employee Plan maintained or contributed to
by the Company or any trade or business which is under common control with the
Company within the meaning of Section 414 of the Code (the "Company Employee
Plans"), the Company has made available to Parent a true and complete copy of,
to the extent applicable, (i) such Company Employee Plan, (ii) the most recent
annual report (Form 5500), (iii) each trust agreement related to such Company
Employee Plan, (iv) the most recent summary plan description for each Company
Employee Plan for which such a description is required, (v) the most recent
actuarial report relating to any Company Employee Plan subject to Title IV of
ERISA and (vi) the most recent IRS determination letter issued with respect to
any Company Employee Plan that is intended to qualify under Section 401(a) of
the Code.
(c) Each Company Employee Plan which is intended to be qualified under
Section 401(a) of the Code has received a favorable determination from the IRS
covering the provisions of the Tax Reform Act of 1986 stating that such Company
13
<PAGE>
Employee Plan is so qualified and nothing has occurred since the date of such
letter that could reasonably be expected to affect the qualified status of such
plan. Each Company Employee Plan has been operated in all material respects in
accordance with its terms and the requirements of applicable law (except as
would not have a Material Adverse Effect on the Company). Neither the Company
nor any ERISA Affiliate of the Company has incurred or is reasonably expected to
incur any liability under Title IV of ERISA in connection with any Company
Employee Plan (except as would not have a material effect on the Company).
(d) To the Company's Knowledge, no employee of the Company or any of its
subsidiaries (i) is in violation of any term of any employment contract, patent
disclosure agreement, noncompetition agreement, or any restrictive covenant with
a former employer relating to the right of any such employee to be employed by
the Company or any of its subsidiaries because of the nature of the business
conducted or presently proposed to be conducted by the Company or any of its
subsidiaries or to the use of trade secrets or proprietary information of others
and (ii) has given notice to the Company or any of its subsidiaries, that any
employee intends to terminate his or her employment with the Company except for
terminations of a nature and number that are consistent with the Company's prior
experience. Neither the Company nor any of its subsidiaries is a party to any
collective bargaining agreement or other labor union contract applicable to
Company Personnel. To the Company's Knowledge, there are no activities or
proceedings of any labor union to organize any employees of the Company or any
of its subsidiaries and there are no strikes, or material slowdowns, work
stoppages or lockouts, or threats thereof by or with respect to any employees of
the Company or any of its subsidiaries. The Company and its subsidiaries are and
have been in compliance with all applicable laws regarding employment practices,
terms and conditions of employment, and wages and hours (including, without
limitation, OSHA, ERISA, WARN or any similar state or local law) (except as
would not have a Material Adverse Effect on the Company).
(e) Except as disclosed in Section 3.11(e) of the Company Disclosure
Schedule, the transactions contemplated by this Agreement (either alone or
together with any other transaction(s) or event(s)) will not (i) entitle any
Company Personnel to severance pay or other similar payments under any Company
Employee Plan, (ii) accelerate the time of payment or vesting or increase the
amount of benefits due under any Company Employee Plan or compensation to any
Company Personnel, (iii) result in any payments (including parachute payments)
under any Company Employee Plan becoming due to any Company Personnel, or (iv)
terminate or modify or give a third party a right to terminate or modify the
provisions or terms of any Company Employee Plan.
SECTION 3.12. Environmental Laws and Regulations.
(a) Except as publicly disclosed in the Company SEC Reports, to the
Company's Knowledge, (i) the properties, assets and operations of the Company
and its subsidiaries are in material compliance with all applicable federal,
state, local and foreign laws and regulations, orders, decrees, judgments,
permits and licenses relating to public and worker health and safety and to the
protection and clean-up of the natural environment (including, without
limitation, ambient air, surface water, ground water, land surface or subsurface
strata) and activities or conditions relating thereto, including, without
limitation, those relating to the generation, handling, disposal, transportation
or release of hazardous materials (collectively "Environmental Laws"), except
for non-compliance that would not have a Material Adverse Effect, which
compliance includes but is not limited to, the possession by the Company and its
subsidiaries of all material permits and other governmental authorizations
required under applicable Environmental Laws and compliance with the terms and
conditions thereof; (ii) none of the Company or its
14
<PAGE>
subsidiaries has received written notice of or, to the Company's Knowledge, is
the subject of any Environmental Claim (defined below) that could reasonably be
expected to have a Material Adverse Effect on the Company; and (iii) to the
Company's Knowledge, there are no circumstances that are reasonably likely to
prevent or interfere with such material compliance in the future.
(b) Except as disclosed in the Company SEC Reports, there is no action,
cause of action, claim, investigation, demand or notice by any person or entity
alleging liability under or non-compliance with any Environmental Law (an
"Environmental Claim") which could reasonably be expected to have a Material
Adverse Effect that is pending or, to the Company's Knowledge, threatened
against the Company or its subsidiaries or, to the Company's Knowledge, against
any person or entity whose liability for any Environmental Claim the Company or
any of its subsidiaries has or may have retained or assumed either contractually
or by operation of law.
SECTION 3.13. Taxes
(a) For purposes of this Agreement: (i) "Tax" or "Taxes" means any taxes,
charges, fees, levies, or other assessments imposed by any U.S. or foreign
governmental entity, whether national, state, county, local or other political
subdivision, including, without limitation, all net income, gross income, sales
and use, rent and occupancy, value added, ad valorem, transfer, gains, profits,
excise, franchise, real and personal property, gross receipt, capital stock,
business and occupation, disability, employment, payroll, license, estimated, or
withholding taxes or charges imposed by any governmental entity, and includes
any interest and penalties on or additions to any such taxes (and includes taxes
for which the Company and/or any of its subsidiaries, as the case may be, may be
liable in its own right, or as the transferee of the assets of, or as successor
to, any other corporation, association, partnership, joint venture, or other
entity, or under Treasury Regulation Section 1.1502-6 or any similar provision
of foreign, state or local law); and (ii) "Tax Return" means a report, return or
other information required to be supplied to a governmental entity with respect
to Taxes including, where permitted or required, group, combined or consolidated
returns for any group of entities that includes the Company or any of its
subsidiaries.
(b) Except as set forth in Section 3.13(b) of the Company Disclosure
Schedule, the Company and each of its subsidiaries, and any affiliated or
combined group of which the Company or any of its subsidiaries is or was a
member for applicable Tax purposes, have (i) filed all federal income and all
other Tax Returns required to be filed by applicable law and all such federal
income and other Tax Returns (A) reflect the liability for Taxes of the Company
and each of its subsidiaries except to the extent that a reserve for Taxes is
reflected on the balance sheet or the notes thereto including in the most recent
consolidated financial statements of the Company and its subsidiaries contained
in the Company SEC Reports, and (B) were filed on a timely basis and (ii) within
the time and in the manner prescribed by law, paid (and until the Closing Time
will pay within the time and in the manner prescribed by law) all Taxes that
were or are due and payable as set forth in such Tax Returns.
(c) Each of the Company and, where applicable, the Company's subsidiaries
has established (and until the Closing Time will maintain on at least a
quarterly basis) on its books and records reserves adequate to pay all Taxes of
the Company or such respective subsidiary, as the case may be, in accordance
with GAAP, which are reflected in the most recent consolidated financial
statements of the Company and its subsidiaries contained in the Company SEC
Reports, as applicable, to the extent required by GAAP.
15
<PAGE>
(d) Except as disclosed in Section 3.13(d) of the Company Disclosure
Schedule, neither the Company nor any subsidiary thereof has requested any
extension of time within which to file any income, franchise or other Tax
Return, which Tax Return has not been filed as of the date hereof.
(e) Except as disclosed in Section 3.13(e) of the Company Disclosure
Schedule, neither the Company nor any subsidiary thereof has executed any
outstanding waivers or comparable consents regarding the application of the
statute of limitations with respect to any income, franchise or other Taxes or
Tax Returns.
(f) Except as disclosed in Section 3.13(f) of the Company Disclosure
Schedule, no deficiency for any Tax which, alone or in the aggregate with any
other deficiency or deficiencies, would exceed $250,000, has been proposed in
writing, asserted in writing, or assessed against the Company and/or any
subsidiary thereof that has not been resolved and paid in full or otherwise
settled, no audits or other administrative proceedings are presently in progress
or, to the Company's Knowledge, pending, or threatened in writing with regard to
any Taxes or Tax Returns of the Company and/or any subsidiary thereof, and no
written claim is currently being made by any authority in a jurisdiction where
any of the Company or any subsidiary thereof, as the case may be, does not file
Tax Returns that it is or may be subject to Tax in that jurisdiction.
(g) Except as disclosed on Section 3.13(g) of the Company Disclosure
Schedule, neither the Company nor any of its subsidiaries is a party to any
agreement relating to allocating or sharing of the payment of, or liability for,
Taxes except an agreement between or among solely the Company and one or more of
such subsidiaries or between such subsidiaries.
(h) The Company does not constitute and for the past five years has not
constituted a "United States real property holding corporation" within the
meaning of Section 897(c)(2) of the Code.
SECTION 3.14. Properties. Section 3.14 of the Company Disclosure Schedule
contains a true and complete list (identifying the relevant owners, lessors and
lessees) of all real properties owned by the Company or any of its subsidiaries.
Each of the Company and its subsidiaries has good and marketable title to all
properties, assets and rights of any kind whatsoever (whether real, personal or
mixed, and whether tangible or intangible) owned by it (collectively, the
"Company Real Assets"), in each case free and clear of any material mortgage,
security interest, deed of trust, claim, charge, title defect or other lien or
encumbrance, except (a) as shown on the consolidated balance sheet of the
Company and its subsidiaries dated December 31, 1998 and the notes thereto, (b)
for any mortgage, security interest, deed of trust, claim, charge, title defect
or other lien or encumbrance arising by reason of (i) taxes, assessments or
governmental charges not yet delinquent or which are being contested in good
faith, (ii) deposits to secure public or statutory obligations in lieu of surety
or appeal bonds entered into in the ordinary course of business, (iii) operation
of law in favor of carriers, warehousemen, landlords, mechanics, materialmen,
laborers, employees or suppliers, incurred in the ordinary course of business
for sums which are not yet delinquent or are being contested in good faith by
negotiations or by appropriate proceedings which suspend the collection thereof
and (iv) matters of public record not having a material adverse effect in the
use or marketability of the Company Real Assets ("Permitted Liens"), or (c) as
set forth on Section 3.14 of the Company Disclosure Schedule. There are no
pending or, to the Company's Knowledge, threatened condemnation proceedings
against or affecting any material Company Real Assets, and none of the material
Company Real
16
<PAGE>
Assets is subject to any commitment or other arrangement for its sale to a third
party outside the ordinary course of business.
SECTION 3.15. Material Contracts and Commitments.
(a) Section 3.15 of the Company Disclosure Schedule contains a true and
complete list of all of the following contracts, agreements and commitments,
whether oral or written ("Contracts"), to which the Company or any of its
subsidiaries is a party or by which any of them or any of their material Company
Real Assets is bound, as each such contract or commitment may have been amended,
modified or supplemented:
(i) all Contracts pursuant to which the Company or its subsidiaries holds a
leasehold interest in or otherwise has an economic interest in any real
property, other than property described in Section 3.14 of the Company
Disclosure Schedule;
(ii) all Contracts granting or obtaining a franchise or license to utilize
a brand name or other rights of a system providing sterilization services,
or granting or obtaining a license or sublicense of any material trademark,
trade name, copyright, patent, service mark, or trade secret, or any rights
therein or application therefor other than for contracts related to
packaged software for the Company's internal use;
(iii) all partnership or joint venture Contracts;
(iv) all loan agreements, notes, bonds, debentures, debt instruments,
evidences of indebtedness, debt securities, or other Contracts relating to
any indebtedness of the Company or any of its subsidiaries in an amount in
excess of $250,000, or involving the direct or indirect guaranty or
suretyship by the Company or any of its subsidiaries of any indebtedness in
an amount in excess of $250,000;
(v) all Contracts that, after the date hereof, obligate the Company or any
of its subsidiaries to pay, pledge, or encumber or restrict assets in an
aggregate amount in excess of $250,000, except with respect to such
Contracts entered into in connection with facilities currently under
construction in which case such excess amount shall be $1,000,000;
(vi) all Contracts by which the Company has committed to extend credit to
third parties other than Contracts entered into with customers in the
ordinary course of business;
(vii) all Contracts with the 25 largest (based on revenue paid to the
Company) customers of the Company during the fiscal year ended March 31,
1999; and
(viii) all Contracts that limit or restrict the ability of the Company or
any of its subsidiaries to compete or otherwise to conduct business in any
material manner or place.
(b) The Company has heretofore made available to the Parent true and
complete copies of all of the Contracts required to be set forth in Section 3.15
of the Company Disclosure Schedule except those required by Section 3.15(vii)
which will be provided to Parent as soon as is practicable after the date
hereof. Each such Contract is
17
<PAGE>
valid and binding in accordance with its terms, and is in full force and effect
(except as set forth in Section 3.15 of the Company Disclosure Schedule),
provided that foregoing representation is to the Company's Knowledge with
respect to the other parties to such Contracts. Neither the Company nor any of
its subsidiaries is in default in any material respect with respect to any such
Contract, nor does any condition exist that with notice or lapse of time or both
would constitute such a material default thereunder or permit any other party
thereto to terminate such Contract. To the Company's Knowledge, no other party
to any such Contract is in default in any material respect with respect to any
such Contract. No party has given any written notice (i) of termination or
cancellation of any such Contract or (ii) that it intends to assert a breach of
any such Contract, whether as a result of the transactions contemplated hereby
or otherwise. Each Contract identified in Section 3.15 of the Company Disclosure
Schedule in response to any item under this Section 3.15 shall be deemed
incorporated by reference to all other items in this Section 3.15.
SECTION 3.16. Intangible Property.
(a) The Company has made available to the Parent a list of the Intangible
Property (as defined below) which is material to the Company and its
subsidiaries in which the Company or any of its subsidiaries has an interest.
(b) Except as set forth on Section 3.16 of the Company Disclosure Schedule:
(i) the Company and its subsidiaries own or have the right to use, all
material Intangible Property used in the conduct of their business as
presently conducted;
(ii) the Company and its subsidiaries have performed all material
obligations required to be performed by them, and are not in default under
any material contract or arrangement relating to any material Intangible
Property;
(iii) the execution, delivery and performance of this Agreement and the
consummation of the transactions contemplated hereby will not breach,
violate or conflict with any agreement related to any material Intangible
Property, will not cause the forfeiture or termination or give rise to a
right of forfeiture or termination of, or in any material way impair the
right of the Company or any of its subsidiaries to use, sell, license or
dispose of or to bring any action for the infringement of, any material
Intangible Property or material portion thereof;
(iv) there are no royalties, honoraria, fees or other payments payable by
the Company or any of its subsidiaries to any person by reason of the
ownership, use, license, sale or disposition of any material Intangible
Property;
(v) the conduct of the business by the Company and its subsidiaries does
not violate any material license or agreement with any third party; and
(vi) neither the Company nor any of its subsidiaries has received any
notice to the effect (or is otherwise aware) that any material Intangible
Property or the use thereof by the Company or any of its subsidiaries
conflicts with any rights of any person.
18
<PAGE>
(c) As used herein "Intangible Property" means all patents, patent
applications (pending or otherwise), material internally developed (including by
third parties) computer software, registered copyrights, and currently used
brand names, service marks, trademarks, tradenames, and all registrations or
applications for registration of any of the foregoing.
SECTION 3.17. Brokers. No broker, finder or investment banker (other than
PaineWebber Incorporated, TM Capital Corp. and SG Cowen Securities Corporation,
the Company's financial advisers, a true and correct copy of whose entire
engagement agreements have been provided to Parent) is entitled to any
brokerage, finder's or other fee or commission in connection with the
transactions contemplated by this Agreement based upon arrangements made by or
on behalf of the Company.
SECTION 3.18. Certain Business Practices. None of the Company, any of its
subsidiaries or any directors or officers of the Company or any of its
subsidiaries (provided that as to the directors and officers of the Company's
Thailand subsidiary such representation is made to the Company's Knowledge), nor
to the Company's Knowledge, agents or employees of the Company or any of its
subsidiaries, has (a) used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to political activity, (b) made
any unlawful payment to foreign or domestic government officials or employees or
to foreign or domestic political parties or campaigns or violated any provision
of the Foreign Corrupt Practices Act of 1977, as amended, or (c) made any other
unlawful payment.
SECTION 3.19 Applicability of State Takeover Statutes. The Section 203
Approval is valid and in full force and effect. Section 203 of the DGCL will not
apply to this Agreement, the Stockholders Agreement, the Offer or the
acquisition of shares pursuant to the Offer or the Stockholders Agreement or the
Merger. No other state takeover statute or similar statute or regulation applies
or purports to apply to this Agreement, the Stockholders Agreement, the Offer,
Merger or the other transactions contemplated hereby or thereby.
SECTION 3.20 Amendment to the Rights Agreement. The Company's Board of
Directors has taken all necessary action (including any amendment thereof) under
the Rights Agreement so that (x) none of the execution or delivery of this
Agreement, or the Stockholders Agreement, consummation of the Offer, or any of
the other transactions contemplated hereby or thereby will cause (i) the Rights
to become exercisable under the Rights Agreement, (ii) Parent, GP or Acquisition
to be deemed an "Acquiring Person" (as defined in the Rights Agreement), or
(iii) the "Distribution Date" (as defined in the Rights Agreement) to occur upon
any such event and (y) the "Expiration Date" (as defined in the Rights
Agreement) of the Rights shall occur immediately prior to the Effective Time.
SECTION 3.21 Opinion of Financial Advisor. The Company has received the
opinion of PaineWebber Incorporated and TM Capital Corp. to the effect that, as
of the date of this Agreement, the consideration to be received in the Offer and
the Merger by the Company's stockholders is fair to the Company's stockholders
from a financial point of view, and a complete and correct signed copy of such
opinion has been, or promptly upon receipt thereof will be, delivered to Parent.
The Company has been authorized by PaineWebber Incorporated and TM Capital Corp.
to permit the inclusion of such opinion in its entirety in the Offer Documents
and the Schedule 14D-9 and the Proxy Statement, so long as such inclusion is in
form and substance reasonably satisfactory to PaineWebber Incorporated and TM
Capital Corp. and its counsel.
19
<PAGE>
SECTION 3.22 Employees. Section 3.22 of the Company Disclosure Schedule
sets forth the following information concerning each employee of the Company
whose base annual salary is in excess of $50,000: (a) name; (b) position; (c)
current base salary; and (d) whether such employee has an employment agreement
and, if so, its expiration date.
ARTICLE 4
REPRESENTATIONS AND WARRANTIES
OF PARENT AND ACQUISITION
Parent and Acquisition hereby represent and warrant to the Company as
follows:
SECTION 4.1. Organization.
(a) Parent is a corporation duly organized, validly existing and in good
standing under the laws of the Kingdom of Belgium, GP is a general partnership
duly organized, validly existing and in good standing under the laws of the
State of Delaware and Acquisition is a corporation duly organized, validly
existing and in good standing under the laws of the State of Delaware, and each
has all requisite power and authority to own, lease and operate its properties
and to carry on its businesses as now being conducted. Each of Parent and
Acquisition has heretofore delivered to the Company accurate and complete copies
of its Certificates of Incorporation and Bylaws as currently in effect.
(b) Each of Parent, GP and Acquisition is duly qualified or licensed and in
good standing to do business in each jurisdiction in which the property owned,
leased or operated by it or the nature of the business conducted by it makes
such qualification or licensing necessary, except in such jurisdictions where
the failure to be so duly qualified or licensed and in good standing would not
have a Parent Material Adverse Effect. The term "Parent Material Adverse Effect"
means any change or effect that is (i) materially adverse to the business,
results of operations, condition (financial or otherwise) or prospects of Parent
and its subsidiaries, taken as a whole, other than any change or effect arising
out of general economic conditions or (ii) that may impair the ability of
Parent, GP and/or Acquisition to consummate the transactions contemplated
hereby.
SECTION 4.2. Authority Relative to this Agreement. Each of Parent, GP and
Acquisition has all necessary corporate power and authority to execute and
deliver this Agreement and to consummate the transactions contemplated hereby.
The execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby have been duly and validly authorized by the
boards of directors of Parent and Acquisition and the partners of GP and by GP
as the sole stockholder of Acquisition and no other corporate proceedings on the
part of Parent, GP or Acquisition are necessary to authorize this Agreement or
to consummate the transactions contemplated hereby. This Agreement has been duly
and validly executed and delivered by each of Parent, GP and Acquisition and
constitutes a valid, legal and binding agreement of each of Parent, GP and
Acquisition enforceable against each of Parent, GP and Acquisition in accordance
with its terms, except as such enforceability may be limited by any applicable
bankruptcy, insolvency, reorganization, moratorium or other similar laws
affecting the enforcement of creditors' rights generally, and except as the
availability of equitable remedies may be limited by the application of general
principles of equity (regardless of whether such equitable principles are
applied in a proceeding at law or in equity).
20
<PAGE>
SECTION 4.3. Information Supplied. Neither the Schedule 14D-1, nor any of
the information supplied or to be supplied by Parent, GP or Acquisition for
inclusion or incorporation by reference in any of the other Disclosure
Statements will, at the respective times that the Proxy Statement (if necessary)
and the Schedule 14D-9 and any amendments thereof or supplements thereto are
filed with the SEC and are first published or sent or given to holders of
Shares, and in the case of any required Proxy Statement, at the time that it or
any amendment thereof or supplement thereto is mailed to the Company's
stockholders or, at the time of the Stockholders' Meeting, if such is required,
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading.
SECTION 4.4. Financing. Parent has or has available to it, and will make
available to Acquisition, all funds necessary to satisfy all of Parent's and
Acquisition's obligations under this Agreement and in connection with the
transactions contemplated hereby including without limitation, sufficient funds
available to purchase all of the Shares that Parent agrees, subject to the terms
and conditions hereof, to purchase hereunder and to pay all related fees and
expenses.
SECTION 4.5. Consents and Approvals; No Violations. Except for filings,
permits, authorizations, consents and approvals as may be required under, and
other applicable requirements of, the Securities Act, the Exchange Act, Blue Sky
Laws, the HSR Act and the securities or antitrust laws of any country other than
the United States, and the filing and acceptance for record of the Merger
Certificate as required by the DGCL, respectively, no filing with or notice to,
and no permit, authorization, consent or approval of, any Governmental Entity is
necessary for the execution and delivery by Parent, GP or Acquisition of this
Agreement or the consummation by Parent, GP or Acquisition of the transactions
contemplated hereby, except where the failure to obtain such permits,
authorizations, consents or approvals or to make such filings or give such
notice would not have a Parent Material Adverse Effect. Neither the execution,
delivery and performance of this Agreement by Parent, GP or Acquisition nor the
consummation by Parent, GP or Acquisition of the transactions contemplated
hereby will (i) conflict with or result in any breach of any provision of the
respective Certificates of Incorporation or Bylaws (or similar governing
documents) of Parent or Acquisition or the partnership agreement of GP, (ii)
result in a violation or breach of or constitute (with or without due notice or
lapse of time or both) a default (or give rise to any right of termination,
amendment, cancellation or acceleration or Lien) under any of the terms,
conditions or provisions of any note, bond, mortgage, indenture, lease, license,
contract, agreement or other instrument or obligation to which Parent, GP or
Acquisition or any of Parent's other subsidiaries is a party or by which any of
them or any of their respective properties or assets may be bound or (iii)
violate any order, writ, injunction, decree, law, statute, rule or regulation
applicable to Parent, GP or Acquisition or any of Parent's other subsidiaries or
any of their respective properties or assets except, in the case of (ii) or
(iii), for violations, breaches or defaults which would not have a Parent
Material Adverse Effect.
ARTICLE 5
COVENANTS
SECTION 5.1. Interim Operations. From the date of this Agreement until the
Closing Time, except as set forth in Section 5.1 of the Company Disclosure
Schedule or as expressly contemplated by any other provision of this Agreement,
unless the Parent
21
<PAGE>
has consented in writing thereto, the Company shall, and shall cause each of its
subsidiaries to:
(a) conduct its business and operations only in the ordinary course of
business consistent with past practice;
(b) use reasonable efforts to preserve intact the business, organization,
goodwill, rights, licenses, permits and franchises of the Company and its
subsidiaries and maintain their existing relationships with customers,
suppliers and other persons having business dealings with them, the loss of
any of which would be reasonably likely to result in a Material Adverse
Effect on the Company;
(c) use reasonable efforts to keep in full force and effect adequate
insurance coverage and maintain and keep its properties and assets in good
repair, working order and condition, normal wear and tear excepted;
(d) not amend or modify its respective charter or certificate of
incorporation, by-laws, or other charter or organization documents;
(e) not authorize for issuance, issue, sell, grant, deliver, pledge or
encumber or agree or commit to issue, sell, grant, deliver, pledge or
encumber any shares of any class or series of capital stock of the Company
or any of its subsidiaries or any other equity or voting security or equity
or voting interest in the Company or any of its subsidiaries, any
securities convertible into or exercisable or exchangeable for any such
shares, securities or interests, or any options, warrants, calls,
commitments, subscriptions or rights to purchase or acquire any such
shares, securities or interests (other than issuances of Shares upon
exercise of Company Stock Options granted prior to the date of this
Agreement and disclosed pursuant to Section 3.2 to directors, officers,
employees and consultants of the Company in accordance with the Company
Option Plans as currently in effect);
(f) not (i) split, combine or reclassify any shares of its stock or issue
or authorize or propose the issuance of any other securities in respect of,
in lieu of, or in substitution for, shares of its stock, (ii) in solely the
case of the Company, declare, set aside or pay any dividends on, or make
other distributions in respect of, any of the Company's stock, or (iii)
repurchase, redeem or otherwise acquire, or agree or commit to repurchase,
redeem or otherwise acquire, any shares of stock or other equity or debt
securities or equity interests of the Company or any of its subsidiaries;
(g) not amend or otherwise modify the terms of any Company Stock Options or
the Company Option Plans, the effect of which shall be to make such terms
more favorable to the holders thereof or persons eligible for participation
therein;
(h) other than regularly scheduled seniority increases in the ordinary
course of business consistent with past practice, not increase the
compensation payable or to become payable to any directors, officers or
employees of the Company or any of its subsidiaries, or grant any severance
or termination pay to, or enter into any employment or severance agreement
with any director or officer of the Company or any of its
22
<PAGE>
subsidiaries, or establish, adopt, enter into or amend in any material
respect or take action to accelerate any material rights or benefits under
any collective bargaining, bonus, profit sharing, thrift, compensation,
stock option, restricted stock, pension, retirement, deferred compensation,
employment, termination, severance or other plan, agreement, trust, fund,
policy or arrangement for the benefit of any director, officer or employee
of the Company of any of its subsidiaries;
(i) not acquire or agree to acquire (including, without limitation, by
merger, consolidation, or acquisition of stock, equity securities or
interests, or assets) any corporation, partnership, joint venture,
association or other business organization or division thereof or otherwise
acquire or agree to acquire any assets of any other person outside the
ordinary course of business consistent with past practice or any interest
in any real properties (whether or not in the ordinary course of business);
(j) not incur, assume or guarantee any indebtedness for borrowed money
(including draw-downs on letters or lines of credit) or issue or sell any
notes, bonds, debentures, debt instruments, evidences of indebtedness or
other debt securities of the Company or any of its subsidiaries or any
options, warrants or rights to purchase or acquire any of the same, except
for (i) renewals of existing bonds and letters of credit in the ordinary
course of business not to exceed $1,000,000 in the aggregate; and (ii)
advances, loans or other indebtedness in the ordinary course of business
consistent with past practice in an aggregate amount not to exceed
$1,000,000;
(k) not sell, lease, license, encumber or otherwise dispose of, or agree to
sell, lease, license, encumber or otherwise dispose of, any material
properties or assets of the Company and its subsidiaries taken as a whole;
(l) not authorize or make any capital expenditures (including by lease) in
excess of $1,000,000 in the aggregate for the Company and all of its
subsidiaries;
(m) not make any material change in any of its accounting or financial
reporting (including tax accounting and reporting) methods, principles or
practices, except as may be required by GAAP or applicable tax laws;
(n) not make any material tax election or settle or compromise any material
United States or foreign tax liability;
(o) except in the ordinary course of business consistent with past
practice, not amend, modify or terminate any Contract required to be listed
in Section 3.15 of the Company Disclosure Schedule or waive, release or
assign any material rights or claims thereunder;
(p) not adopt a plan of complete or partial liquidation, dissolution,
merger, consolidation, restructuring, recapitalization or other
reorganization of the Company or any of its subsidiaries; and
(q) except as to subsections (a), (b) and (c) of this Section 5.1, not
agree or commit in writing or otherwise to do any of the foregoing.
23
<PAGE>
SECTION 5.2. Stockholders' Meeting.
(a) The Company, acting through the Board, shall, if required for the
Merger under the DGCL:
(i) duly call, give notice of, convene and hold a meeting of its
stockholders (the "Stockholders' Meeting"), to be held as soon as
practicable after the Tender Offer Purchase Time for the purpose of
considering and taking action upon this Agreement;
(ii) except as otherwise permitted under Section 5.3, include in the
Proxy Statement (A) the recommendation of the Board that stockholders of
the Company vote in favor of the approval and adoption of this Agreement,
the Merger and the other transactions contemplated hereby, and (B) a
statement that the Board believes that the consideration to be received by
the stockholders of the Company pursuant to the Merger is fair to such
stockholders;
(iii) except as otherwise permitted under Section 5.3, use reasonable
efforts (A) to obtain and furnish the information required to be included
by it in the Disclosure Statements and, after consultation with Parent and
providing Parent with a reasonable opportunity to review and comment upon
the Proxy Statement, cause the Proxy Statement to be mailed to its
stockholders at the earliest practicable time following the Tender Offer
Purchase Time, and (B) to obtain the necessary approvals by its
stockholders of this Agreement and the transactions contemplated hereby. At
such meeting, Parent, GP and Acquisition will, and will cause their
affiliates to, vote all Shares owned by them in favor of approval and
adoption of this Agreement, the Merger and the transactions contemplated
hereby.
SECTION 5.3. Other Potential Acquirers.
(a) From and after the date of this Agreement until the earlier of the
Effective Time or termination of this Agreement pursuant to its terms, the
Company and its subsidiaries shall not, and will instruct their respective
directors, officers, employees, representatives, investment bankers, agents and
affiliates not to, directly or indirectly, (i) solicit or encourage submission
of, any inquiries, proposals or offers by any person, entity or group (other
than Parent and its affiliates, agents and representatives), or (ii) participate
in any discussions or negotiations with, or disclose any non-public information
concerning the Company or any of its subsidiaries to, or afford any access to
the properties, books or records of the Company or any of its subsidiaries to,
or otherwise assist or facilitate, or enter into or resolve to enter into any
agreement or understanding with, any person, entity or group (other than Parent
and its affiliates, agents and representatives), in connection with any
Acquisition Proposal with respect to the Company. For the purposes of this
Agreement, an "Acquisition Proposal" with respect to an entity means any
proposal or offer relating to (i) any merger, consolidation, sale of substantial
assets or similar transactions involving the entity or any subsidiaries of the
entity (other than sales of assets or inventory in the ordinary course of
business or as permitted under the terms of this Agreement), (ii) the
acquisition by any person of beneficial ownership or a right to acquire
beneficial ownership of, or the formation of any "group" (as defined under
Section 13(d) of the Exchange Act and the rules and
24
<PAGE>
regulations thereunder) which beneficially owns, or has the right to acquire
beneficial ownership of, 10% or more of the then outstanding shares of capital
stock of the entity (except for acquisitions for passive investment purposes
only in circumstances where the person or group qualifies for and files a
Schedule 13G with respect thereto); (iii) the adoption by the entity of a plan
of liquidation or the declaration or payment of an extraordinary dividend; (iv)
the repurchase by the entity of more than 20% of its outstanding shares of
voting stock; (v) the acquisition by the entity of direct or indirect ownership
of a business where annual revenue, net income or assets is greater than 20% of
the entity; or (vi) any public announcement of a proposal, plan or intention to
do any of the foregoing or any agreement to engage in any of the foregoing. The
Company will, and will cause its subsidiaries and their respective directors,
officers, employees, representatives and agents, to immediately cease any and
all existing activities, discussions or negotiations with any parties conducted
heretofore with respect to any of the foregoing. The Company will (i) notify
Parent as promptly as practicable if any inquiry or proposal is made or any
information or access is requested in connection with an Acquisition Proposal or
potential Acquisition Proposal and (ii) as promptly as practicable notify Parent
of the terms and conditions of any such Acquisition Proposal. In addition,
subject to the other provisions of this Section 5.3(a), from and after the date
of this Agreement until the earlier of the Effective Time and termination of
this Agreement pursuant to its terms, the Company and its subsidiaries will not,
and will instruct their respective directors, officers, employees,
representatives, investment bankers, agents and affiliates not to, directly or
indirectly, make or authorize any public statement, recommendation or
solicitation in support of any Acquisition Proposal made by any person, entity
or group (other than Parent or Acquisition); provided, however, that nothing
herein shall prohibit the Company's Board of Directors from taking and
disclosing to the Company's stockholders a position with respect to a tender
offer pursuant to Rules 14d-9 and 14e-2 promulgated under the Exchange Act.
(b) Except as allowed under Section 5.3(b), the Board will not withdraw or
modify in a manner adverse to Parent or Acquisition its recommendation of the
transactions contemplated hereby or approve or recommend any Acquisition
Proposal. Notwithstanding the provisions of paragraph (a) above, prior to
consummation of the Offer, the Company may, to the extent the Board of Directors
of the Company determines, in good faith, after consultation with outside legal
counsel, that the Board's fiduciary duties under applicable law require it to do
so, participate in discussions or negotiations with, and, subject to the
requirements of paragraph (c), below, furnish information to any person, entity
or group after such person, entity or group has delivered to the Company in
writing, an unsolicited bona fide Acquisition Proposal which the Board of
Directors of the Company in its good faith reasonable judgment determines, after
consultation with its independent financial advisors, would result in a
transaction more favorable than the Offer and the Merger to the stockholders of
the Company from a financial point of view and for which financing, to the
extent required, is then committed or which, in the good faith reasonable
judgement of the Board of Directors of the Company (based upon the advice of
independent financial advisors) is reasonably capable of being financed by such
person, entity or group and which is likely to be consummated (a "Superior
Proposal"). In the event the Company receives a Superior Proposal nothing
contained in this Agreement (but subject to the terms hereof) will prevent the
Board of Directors of the Company from recommending such Superior Proposal to
the Company's stockholders, if the Board determines, in good faith, after
consultation with outside legal counsel, that such action is required by its
fiduciary duties under applicable law, provided, however, that the Company shall
not recommend to its stockholders a Superior Proposal for a period of not less
than 72 hours after Parent's receipt of a copy of such Superior Proposal (or a
description of the terms and conditions thereof, if not in writing).
25
<PAGE>
(c) Notwithstanding anything to the contrary herein, the Company will not
provide any nonpublic information to a third party unless: (x) the Company
provides such nonpublic information pursuant to a nondisclosure agreement with
terms regarding the protection of confidential information at least as
restrictive as such terms in the Confidentiality Agreement (as defined below);
and (y) such nonpublic information has been previously delivered to Parent.
SECTION 5.4 [Intentionally Omitted].
SECTION 5.5 Access to Information. From the date of this Agreement until
the Closing Time, upon reasonable prior notice, the Company shall (and shall
cause each of its subsidiaries to) give the Parent and its representatives
(including lenders to and financing sources for such party) full access to the
officers, employees, agents, books, records, contracts, commitments, properties,
offices and other facilities of it and its subsidiaries, and shall furnish
promptly to the Parent and its representatives such financial and operating data
and other information concerning the business, operations, properties,
contracts, records and personnel of the Company and its subsidiaries as the
Parent may from time to time reasonably request. Parent and Acquisition will
make all reasonable efforts to minimize any disruption to the businesses of the
Company and its subsidiaries which may result from the access to properties and
employees and for data and information hereunder. All information obtained by
the Parent pursuant to this Section 5.5 shall be kept confidential in accordance
with the confidentiality provisions of the Non-Disclosure Agreement between
Parent and the Company dated May 17, 1999 (the "Confidentiality Agreement"). No
representations and warranties or conditions to the consummation of the Merger
contained herein or in any certificate or instrument delivered in connection
herewith shall be deemed waived or otherwise affected by any investigation made
by the parties or their respective representatives.
SECTION 5.6. Further Actions.
(a) Each of the parties hereto shall use its best efforts to take, or cause
to be taken, all actions, and to do, or cause to be done, all things necessary,
proper or advisable under applicable laws and regulations, and consult and fully
cooperate with and provide reasonable assistance to each other party hereto and
their respective representatives in order, to consummate and make effective the
transactions contemplated by this Agreement as promptly as practicable
hereafter, including, without limitation, (i) using reasonable efforts to make
all filings, applications, notifications, reports, submissions and registrations
with, and to obtain all consents, approvals, authorizations or permits of,
Governmental Entities or other persons or entities as are necessary for the
consummation of the Merger and the other transactions contemplated hereby
(including, without limitation, pursuant to the HSR Act, the Securities Act, the
Exchange Act, Blue Sky Laws, Delaware law and other applicable laws and
regulations in effect in the United States, Belgium or any other jurisdiction),
and (ii) taking such actions and doing such things as any other party hereto may
reasonably request in order to cause any of the conditions to such other party's
obligation to consummate the Merger as specified in Article 8 of this Agreement
to be fully satisfied. Prior to making any application to or filing with any
Governmental Entity or other person or entity in connection with this Agreement,
the Company, on the one hand, and the Parent, on the other hand, shall provide
the other with drafts thereof and afford the other a reasonable opportunity to
comment on such drafts.
(b) Without limiting the generality of the foregoing, each of the Parent
and the Company agree to cooperate and use reasonable efforts to vigorously
contest and resist any action, suit, proceeding or claim, and to have vacated,
lifted, reversed or
26
<PAGE>
overturned any injunction, order, judgment or decree (whether temporary,
preliminary or permanent), that delays, prevents or otherwise restricts the
consummation of the Merger or any other transaction contemplated by this
Agreement, and to take any and all actions (including, without limitation, the
disposition of assets, divestiture of businesses, or the withdrawal from doing
business in particular jurisdictions) as may be required by Governmental
Entities as a condition to the granting of any such necessary approvals or as
may be required to avoid, vacate, lift, reverse or overturn any injunction,
order, judgment, decree or regulatory action; provided, however, that in no
event shall any party hereto take, or be required to take, any action that could
reasonably be expected to have a Material Adverse Effect on the Company or that
individually or in the aggregate could reasonably be expected to have a Parent
Material Effect.
SECTION 5.7. HSR Matters. Each party hereto shall make an appropriate
filing of a Notification and Report Form pursuant to the HSR Act with respect to
the transactions contemplated hereby as promptly as practicable after the date
hereof. Each such filing shall request early termination of the waiting periods
imposed by the HSR Act. Each party hereby agrees to use its reasonable best
efforts to cause a termination of the waiting period under the HSR Act without
the entry by a court of competent jurisdiction of an order enjoining the
consummation of the transactions contemplated hereby at as early a date as
possible. Each party also agrees to respond promptly to all investigatory
requests as may be made by the government. In the event that a Request for
Additional Information is issued under the HSR Act, each party agrees to furnish
all information required and to comply substantially with such request as soon
as is practicable after its receipt thereof so that any additional applicable
waiting period under the HSR Act may commence. Each party will keep the other
party apprised of the status of any inquiries made of such party by the
Department of Justice, Federal Trade Commission or any other governmental agency
or authority or members of their respective staffs with respect to this
Agreement or the transactions contemplated hereby.
SECTION 5.8. Public Announcements. Parent, Acquisition and the Company, as
the case may be, will consult with one another before issuing any press release
or otherwise making any public statements with respect to the transactions
contemplated by this Agreement, including, without limitation, the Merger, and
shall not issue any such press release or make any such public statement prior
to such consultation except to the extent that such consultation may be
prohibited by applicable law or such a disclosure or release is required by
obligations pursuant to any listing agreement with the Brussels Stock Exchange
or Nasdaq as determined by Parent or the Company, as the case may be.
SECTION 5.9. Employee Benefit Matters; Company Stock Options. The Company
shall, or shall cause one of its subsidiaries to, take such action effective as
of the Effective Time with respect to any Company Employee Plan as Parent shall
reasonably request, including termination of any such plan. The Company shall
(a) cooperate with Parent and Acquisition in obtaining waivers, in form and
substance reasonably satisfactory to Parent and Acquisition, of all terms of the
Company Option Plans and all terms of outstanding Company Stock Options, which
terms could prevent, restrict or impair the ability of Parent, Acquisition and
the Company to effectuate fully the provisions of Section 2.10, and (b) use
reasonable efforts to cause its Compensation Committee to interpret the Company
Option Plan, to the extent possible, so as to enable the Company, Parent and
Acquisition to effectuate fully the provisions of Section 2.10.
SECTION 5.10. Notification of Certain Matters. The Company shall give
prompt notice to Parent and Parent shall give prompt notice to the Company, of
(i) the occurrence or nonoccurrence of any event the occurrence or nonoccurrence
of
27
<PAGE>
which would be likely to cause (A) any representation or warranty contained in
this Agreement to be untrue or inaccurate in any material respect at or prior to
the Effective Time or (B) any covenant, condition or agreement contained in this
Agreement not to be complied with or satisfied in all material respects and (ii)
any material failure of the Company, Parent, GP or Acquisition, as the case may
be, to comply with or satisfy any covenant, condition or agreement to be
complied with or satisfied by it hereunder; provided, however, that the delivery
of any notice pursuant to this Section 5.10 shall not cure such breach or
non-compliance or limit or otherwise affect the remedies available hereunder to
the party receiving such notice.
SECTION 5.11. Guarantee of Performance. Parent hereby guarantees the
performance by Acquisition and GP of their obligations under this Agreement.
SECTION 5.12 Indemnification; Directors' and Officers' Insurance.
(a) Parent and Acquisition agree that all rights to indemnification for
acts or omissions occurring prior to the Effective Time now existing in favor of
the current or former directors or officers (the "Indemnified Parties") of the
Company and its subsidiaries as provided in their respective certificates of
incorporation or bylaws (or similar organizational documents) or existing
indemnification contracts shall survive the Merger and shall continue in full
force and effect in accordance with their terms.
(b) For six years from the Effective Time, Parent shall maintain in effect
the Company's current directors' and officers' liability insurance or insurance
policies with substantially equivalent coverage covering those persons who are
currently covered by the Company's directors' and officers' liability insurance
policy (a copy of which has been heretofore delivered to Parent).
(c) This Section 5.12 shall survive the consummation of the Merger at the
Effective Time, is intended to benefit the Company, Parent, the Acquisition and
the Indemnified Parties, and shall be binding on all successors and assigns of
Parent and the Acquisition.
SECTION 5.13 State Takeover Laws. Notwithstanding any other provision of
this Agreement, in no event shall the Section 203 Approval be withdrawn, revoked
or modified by the Board. If any state takeover statute other than Section 203
of the DGCL becomes or is deemed to become applicable to the Offer, the
acquisition of the Shares pursuant to the Offer or the Stockholders Agreement or
the Merger, the Company shall take all action necessary to render such statute
inapplicable to all of the foregoing.
SECTION 5.14 Employee Benefits. Following the Effective Time, the Surviving
Corporation will provide the persons employed by the Company immediately prior
to the Effective Time, for so long as such persons remain employed by the
Surviving Corporation with benefits (other than stock options) in the aggregate
which are substantially comparable to those provided to such persons by the
Company immediately prior to the Effective Time.
ARTICLE 6
DISSENTING SHARES; EXCHANGE OF SHARES
SECTION 6.1 Dissenting Shares. Notwithstanding anything in this Agreement
to the contrary, in the event that dissenters' rights are available in
connection with the Merger pursuant to Section 262 of the DGCL, Shares that are
issued and
28
<PAGE>
outstanding immediately prior to the Effective Time and that are held by
stockholders who did not vote in favor of the Merger and who comply with all of
the relevant provisions of Section 262 of the DGCL (the "Dissenting Shares")
shall not be converted into or be exchangeable for the right to receive the Cash
Merger Consideration, but instead shall be converted into the right to receive
such consideration as may be determined to be due to such stockholders pursuant
to Section 262 of the DGCL, unless and until such holders shall have failed to
perfect or shall have effectively withdrawn or lost their rights to appraisal
under the DGCL. If any such holder shall have failed to perfect or shall have
effectively withdrawn or lost such right, such holder's Shares shall thereupon
be deemed to have been converted into and to have become exchangeable for the
right to receive, as of the Effective Time, the Cash Merger Consideration
without any interest thereon. The Company shall give Parent (i) prompt notice of
any written demands for appraisal of Shares received by the Company and (ii) the
opportunity to participate in all negotiations and proceedings with respect to
any such demands. The Company shall not, without the prior written consent of
Parent, voluntarily make any payment with respect to, or settle or offer to
settle, any such demands.
ARTICLE 7
CONDITIONS TO THE OFFER
SECTION 7.1. Conditions to the Offer. (a) Notwithstanding any other
provisions of the Offer, Acquisition shall not be required to accept for payment
or, subject to any applicable rules and regulations of the SEC, including Rule
14e-l(c) under the Exchange Act (relating to Acquisition's obligation to pay for
or return tendered Shares promptly after termination or withdrawal of the
Offer), pay for, and may delay the acceptance for payment of or, subject to the
restrictions referred to above, the payment for, any tendered Shares, and may
amend the Offer consistent with the terms of this Agreement, including extending
the deadline for tendering Shares, or terminate the Offer, if any of the
following events shall occur:
(i) from the date of this Agreement until the Tender Offer Purchase Time,
there shall have occurred any change, event, occurrence or circumstance
which, individually or in the aggregate, has a Material Change (as defined
below) on the Company (except for changes, events, occurrences or
circumstances with respect to general economic conditions). "Material
Change" means any change or effect that is materially adverse to the
business, properties or financial condition of the Company; provided,
however, that (x) the commencement of any litigation against the Company or
its subsidiaries after the date of this Agreement which is related to this
Agreement or the transactions contemplated hereby or any adverse change,
event or effect that is proximately caused by such litigation that is
initiated or threatened after the date of this Agreement against the
Company or any of its subsidiaries and (y) any adverse change resulting
from any action taken by the Company that was approved by Parent under
Section 5.1 of this Agreement shall not be a Material Change; and provided
further, however, that if the Offer is consummated after July 31, 1999 the
following shall not be taken into account in determining whether there has
been or would be a Material Change with respect to the Company to the
extent such events occur subsequent to July 31, 1999:
29
<PAGE>
(a) a reduction of up to 25% of the (i) average monthly consolidated
revenue and net profit of the Company compared to the average monthly
consolidated revenue and net profit of the Company during the 12
months immediately preceding the date of this Agreement or (ii) the
net worth of the Company compared to the December 31, 1998 balance
sheet;
(b) any change in the assets of the Company in connection with
obtaining required regulatory approvals; or
(c) any voluntary termination after the date of this Agreement of
officers or other key employees of the Company;
(ii) from the date of this Agreement until the Tender Offer Purchase Time,
any Governmental Entity or court of competent jurisdiction shall have
enacted, issued, promulgated, enforced or entered any statute, rule,
regulation, executive order, decree, injunction or other order (and if
temporary or preliminary, not vacated within five (5) business days of its
entry), except with regard to HSR Act approval which shall be governed by
Section 7.1(a)(vii), which is in effect at the Tender Offer Purchase Time
and which (1) makes the acceptance for payment of, or the payment for, some
or all of the Shares illegal or otherwise prohibits or restricts
consummation of the Offer, the Merger or any of the other transactions
contemplated hereby, (2) imposes material limitations on the ability of
Parent, GP or Acquisition to acquire or hold or to exercise any rights of
ownership of the Shares, or effectively to manage or control the Company
and its business, assets and properties or (3) would result in a Material
Change to the Company; provided, however, that the parties shall use
reasonable efforts (subject to the proviso in Section 5.6(b)) to cause any
such decree, judgment or other order to be vacated or lifted as soon as is
practicable;
(iii) the representations and warranties of the Company set forth in this
Agreement shall not (A) have been true and correct in one or more material
respects on the date hereof or (B) (except with respect to the
representations and warranties set forth in Sections 3.8, 3.9, 3.14, 3.15,
3.22, 3.13(c), (d), (e), (f), (g) and (h) and 3.16(a), (b)(i), (ii), (iv),
(v) and (vi)) be true and correct in one or more material respects as of
the scheduled expiration date (as such date may be extended) of the Offer
as though made on and as of such date or the Company shall have breached or
failed in any respect to perform or comply with any material obligation,
agreement or covenant required by this Agreement to be performed or
complied with by it (including without limitation the provisions of Section
5.3) except, in each case with respect to clause B, (1) for changes
specifically permitted by the Agreement and (2)(x) for those
representations and warranties that address matters only as of a particular
date which are true and correct as of such date or (y) where the failure of
representations and warranties (without regard to materiality
qualifications therein contained) to be true and correct, or the
performance or compliance with such obligations, agreements, or covenants,
would not, individually or in the aggregate, result in a Material Change to
the Company;
30
<PAGE>
(iv) from the date of this Agreement until the Tender Offer Purchase Time,
this Agreement shall have been terminated in accordance with its terms;
(v) from the date of this Agreement until the Tender Offer Purchase Time
the Board of Directors of the Company or any committee thereof shall have
(1) withdrawn or modified (including without limitation, by amendment of
the Company's Schedule 14D-9) in a manner adverse to Parent or Acquisition
its approval or recommendation of the Offer, the Merger or the Agreement,
(2) approved or recommended any Acquisition Proposal by a third party other
than the Offer and the Merger, (3) resolved to do any of the foregoing, or
(4) upon a request to reaffirm the Company's approval or recommendation of
the Offer, the Agreement or the Merger, the Board of Directors of the
Company shall fail to do so within two business days after such request is
made;
(vi) from the date of this Agreement until the Tender Offer Purchase Time,
any of the consents, approvals, authorizations, orders or permits required
to be obtained by the Company, Parent, GP or Acquisition, or their
respective subsidiaries in connection with the Offer or the Merger from, or
filings or registrations required to be made by any of the same prior to
the Tender Offer Purchase Time with, any Governmental Entity in connection
with the execution, delivery and performance of this Agreement (including
without limitation the termination or expiration of any applicable waiting
period or the receipt of any required clearance under the HSR Act) shall
not have been obtained or made or shall have been obtained or made subject
to conditions or requirements, which (A) make the acceptance for payment
of, or the payment for the Shares illegal or otherwise prohibits or
restricts the consummation of the Offer or the Merger or (B) have a Parent
Material Adverse Effect or result in a Material Change to the Company or
(C) impose material limitations on the ability of Parent, GP or Acquisition
effectively to manage or control the Company;
(vii) from the date of this Agreement until the Tender Offer Purchase Time,
in the case of HSR Act approval, any Governmental Entity or court of
competent jurisdiction shall have entered a final, non-appealable order
enjoining the consummation of the Merger;
(viii) from the date of this Agreement until the Tender Offer Purchase
Time, there shall have occurred (A) the declaration of a banking moratorium
or any suspension of payments in respect of banks in the United States or
in Belgium or (B) the commencement of a war or armed hostilities involving
the United States or Belgium and resulting in a Material Change to the
Company or having a Parent Material Adverse Effect or materially adversely
affecting (or materially delaying) the consummation of the Offer.
(b) The conditions set forth in Section 7.1(a) are for the sole benefit of
Parent, GP and Acquisition and may be asserted by Parent regardless of any
circumstances giving rise to any condition and may be waived by Parent, in whole
or in part, at any time and from time to time, in the sole discretion of Parent.
The failure by Parent (or any affiliate of Parent) at any time to exercise any
of the foregoing rights will not be deemed a waiver of any right and each right
will be deemed an ongoing right which may be asserted at any time and from time
to time.
31
<PAGE>
(c) Notwithstanding the foregoing, if within the "Cure Time" (defined
below) the Company has cured one or more conditions set forth in subsections
(a)(i), (ii), or (iii) of Section 7.1, and following such cure, no condition
enumerated in Section 7.1(a) continues to exist, then this Article shall not
relieve Parent, GP and Acquisition of their obligations hereunder with respect
to the Offer. For purposes hereof, "Cure Time" means the earlier of (A) two (2)
full business days before the scheduled expiration date of the Offer (as such
period may be extended) or (B) ten (10) full business days following notice to
the Company of the existence of such condition.
ARTICLE 8
CONDITIONS TO CONSUMMATION OF THE MERGER
SECTION 8.1. Conditions to Each Party's Obligations to Effect the Merger.
The respective obligations of each party hereto to effect the Merger are subject
to the satisfaction at or prior to the Closing Time of the following conditions:
(a) this Agreement, the Merger and the other transactions contemplated
hereby shall have been approved by all necessary corporate action of the
Company, including, if necessary, adoption by vote of the stockholders of the
Company;
(b) no Governmental Entity or court of competent jurisdiction shall have
enacted, issued, promulgated, enforced or entered any statute, rule, regulation,
executive order, decree, injunction or other order (and if temporary or
preliminary, not vacated within five business days of its entry) which is in
effect and which (1) makes the payment of the Cash Merger Consideration illegal
or otherwise prohibits or restricts consummation of the Merger or any of the
other applicable transactions contemplated hereby, or (2) imposes material
limitations on the ability of Parent, GP or Acquisition to acquire or hold or to
exercise any rights of ownership of the Surviving Corporation, or effectively to
manage or control the Surviving Corporation and its business, assets and
properties;
(c) any waiting period applicable to the Merger under the HSR Act shall
have terminated or expired and any other governmental or regulatory notices or
approvals required with respect to the transactions contemplated hereby shall
have been either filed or received; and
(d) Acquisition shall have purchased Shares pursuant to the Offer.
ARTICLE 9
TERMINATION; AMENDMENT; WAIVER
SECTION 9.1. Termination. This Agreement may be terminated, at any time
prior to the Effective Time, whether before or after approval by the
stockholders of the Company:
(a) by mutual written agreement of the Boards of Directors of Parent and
the Company;
(b) by either Parent or the Company;
32
<PAGE>
(i) if the Offer (as may be extended in accordance with the terms
hereof) shall be terminated or expire without any Shares having been
purchased pursuant to the Offer; provided, however, that a party shall not
be entitled to terminate this Agreement pursuant to this Section 9.l(b)(i)
if it is in material breach of its representations and warranties,
covenants or other obligations under this Agreement; and provided, further,
however, that if the Offer is not consummated due to a failure to obtain
clearance under the HSR Act, Parent may not terminate this Agreement until
December 31, 1999 and the Company may not terminate this Agreement until
April 1, 2000; or
(ii) if any court of competent jurisdiction in the United States or
other United States governmental body shall have issued an order, decree or
ruling or taken any other action restraining, enjoining or otherwise
prohibiting the Offer or the Merger and such order, decree, ruling or other
action shall have become final and nonappealable;
(c) by Parent:
(i) if the Board of Directors of the Company or any committee thereof
shall have approved, or recommended that stockholders of the Company accept
or approve, an Acquisition Proposal by a third party, or shall have
resolved to do any of the foregoing;
(ii) if the Board of Directors of the Company or any committee thereof
shall have withdrawn or modified its approval of, or recommendation that
the stockholders of the Company accept or approve (as the case may be), the
Offer, this Agreement and the Merger, or shall have resolved to do any of
the foregoing;
(iii) if the Company shall have failed to include in the Schedule
14D-9 the recommendation of the Board of Directors of the Company that the
stockholders of the Company accept the Offer;
(iv) prior to the purchase of the Shares pursuant to the Offer, if the
Company is in material breach of any of its covenants or obligations under
this Agreement, or any representation or warranty of the Company contained
in this Agreement shall have been incorrect, in any material respect, when
made;
(v) prior to the purchase of Shares pursuant to the Offer, in the
event that the conditions to the Offer set forth in Section 7.1 shall not
be satisfied, provided, that Parent may not terminate this Agreement due to
a failure to obtain clearance under the HSR Act until December 31, 1999; or
(vi) after purchase of the Shares pursuant to the Offer, if the
Company is in violation or breach of Section 1.3.
(d) by the Company:
(i) if the Offer shall not have been commenced in accordance with
Section 1.1, or Parent or Acquisition shall have failed to purchase validly
tendered Shares in violation of the terms of the Offer within ten business
days after the expiration of the Offer; provided, however, that the
33
<PAGE>
Company shall not be entitled to terminate this Agreement pursuant to this
Section 9.1(d)(i) if it is in material breach of its representations and
warranties, covenants or other obligations under this Agreement;
(ii) if the Board of Directors of the Company has resolved to, and in
fact does, recommend to the Company's Stockholders that they accept a
Superior Proposal, provided that all the provisions of Section 5.3 have
been fully complied with and the Break-up Fee has been paid to Parent in
accordance with Section 9.3(b);
(iii) prior to the purchase of Shares pursuant to the Offer, if Parent
or Acquisition is in material breach of any of its covenants or obligations
under this Agreement, or any representation or warranty of Parent or
Purchaser contained in this Agreement shall have been incorrect, in any
material respect, when made; or
(iv) at any time after March 31, 2000 if the Offer has not been
consummated due to a failure to obtain clearance under the HSR Act;
provided, however, that the Company shall not be entitled to terminate this
Agreement pursuant to this Section 9.1(d)(iv) if it is in material breach
of its representations and warranties, covenants or other obligations under
this Agreement.
SECTION 9.2. Procedure and Effect of Termination. In the event of the
termination of this Agreement by the Company or Parent or both of them pursuant
to Section 9.1, the terminating party shall provide written notice of such
termination to the other party and this Agreement shall forthwith become void
and there shall be no liability on the part of Parent, Purchaser or the Company,
except that the confidentiality provisions of Section 5.5, the first sentence of
Section 5.13, and Sections 9.2 and 9.3 shall survive the termination of this
Agreement. The foregoing shall not relieve any party for liability for damages
actually incurred as a result of any breach of this Agreement.
SECTION 9.3. Fees and Expenses.
(a) Except as otherwise provided in this Agreement and whether or not the
transactions contemplated by the Offer and this Agreement are consummated, all
costs and expenses incurred in connection with the transactions contemplated by
the Offer and this Agreement shall be paid by the party incurring such expenses.
(b) The Company shall pay to Parent, an amount equal to $7,500,000 (the
"Break-Up Fee"), if any of the following shall occur:
(i) if the Board of Directors of the Company or any committee thereof
shall have approved, or recommended that stockholders of the Company
accept or approve, an Acquisition Proposal by a third party, or shall
have resolved to do any of the foregoing;
(ii) if the Board of Directors of the Company or any committee thereof
shall have withdrawn or modified its approval of, or recommendation
that the stockholders of the Company accept or approve (as the case
may be), the Offer, this Agreement and the Merger, or shall have
resolved to do any of the foregoing; or
34
<PAGE>
(iii) if the Company shall have failed to include in the Schedule 14D-9 the
recommendation of the Board of Directors of the Company that the
stockholders of the Company accept the Offer.
Such Break-up Fee shall be payable within 30 days of such event.
(c) Parent shall pay to the Company the sum of $8,000,000 if the Offer has
not been consummated, and (i) Parent terminates this Agreement during the period
from December 31, 1999 through February 15, 2000 due to a failure to obtain
clearance under the HSR Act and (ii) Parent shall have refused to consent to any
divestiture by the Company required for clearance under the HSR Act.
(d) Parent shall pay to the Company the sum of $15,000,000 if the Offer has
not been consummated, and (i) Parent terminates the Agreement at any time after
February 15, 2000 due to a failure to obtain clearance under the HSR Act and
(ii) Parent shall have refused to consent to any divestiture by the Company
required for clearance under the HSR Act.
(e) Parent shall pay to the Company the sum of $15,000,000 if the Company
terminates the Agreement pursuant to Section 9.1(d)(iv) and Parent shall have
refused to consent to any divestiture by the Company required for clearance
under the HSR Act.
SECTION 9.4. Amendment. This Agreement may be amended by each of the
parties by action taken by or on behalf of their respective Boards of Directors
at any time prior to the Effective Time; provided, however, that (i) such
amendment shall be in writing signed by all of the parties, (ii) any such
waiver, amendment or supplement by the Company shall be effective as against the
Company only if approved by a majority of the Continuing Directors and (iii)
after adoption of this Agreement and the Merger by the stockholders of the
Company, no amendment may be made without the further approval of the
stockholders of the Company which reduces the Merger Consideration or changes
the form thereof or changes any other terms and conditions of this Agreement if
the changes, alone or in the aggregate, would materially adversely affect the
stockholders of the Company.
SECTION 9.5. Waiver. At any time prior to the Effective Time, whether
before or after the Company's Stockholders Meeting, any party hereto, by action
taken by its Board of Directors, may (i) extend the time for the performance of
any of the obligations or other acts of any other party hereto or (ii) subject
to the provisions of Section 9.4, waive compliance with any of the agreements of
any other party or with any conditions to its own obligations. Any agreement on
the part of a party hereto to any such extension or waiver shall be valid only
if set forth in an instrument in writing signed on behalf of such party by a
duly authorized officer of such party. Notwithstanding the above, any waiver
given shall not apply to any subsequent failure of compliance with agreements of
the other party or conditions to its own obligations.
ARTICLE 10
MISCELLANEOUS
SECTION 10.1. Nonsurvival of Representations and Warranties. The
representations and warranties made herein shall not survive beyond the Tender
Offer Purchase Time or a termination of this Agreement; provided, however, that
this Section
35
<PAGE>
10.1 shall not limit any covenant or agreement of the parties hereto which by
its terms requires performance after the Tender Offer Purchase Time including,
without limitation, the covenants and agreements set forth in Article 5.
SECTION 10.2. Entire Agreement; Assignment. This Agreement (a) constitutes
the entire agreement between the parties hereto with respect to the subject
matter hereof and supersedes all other prior agreements and understandings both
written and oral between the parties with respect to the subject matter hereof
and (b) shall not be assigned by operation of law or otherwise.
SECTION 10.3. Validity. If any provision of this Agreement or the
application thereof to any person or circumstance is held invalid or
unenforceable the remainder of this Agreement and the application of such
provision to other persons or circumstances shall not be affected thereby and to
such end the provisions of this Agreement are agreed to be severable.
SECTION 10.4. Notices. All notices, requests, claims, demands and other
communications hereunder shall be in writing and shall be given (and shall be
deemed to have been duly given upon receipt) by delivery in person, by facsimile
or by registered or certified mail (postage prepaid, return receipt requested)
to each other party as follows:
if to Parent, GP or Acquisition: ION BEAM APPLICATIONS S.A.
Chemin du Cyclotron, 3
B-1348 Lourain-la-Neuve
Belgium
Telecopier: 011-32-10-47-5810
Attention: Pierre Mottet
with a copy to: Dorsey & Whitney LLP
250 Park Avenue
New York, New York 10177
Telecopier: (212) 953-7201
Attention: Ramon P. Marks, Esq.
Kevin T. Collins, Esq.
if to the Company to: STERIGENICS INTERNATIONAL,
INC.
4020 Clipper Court
Fremont, California 94538
Telecopier:
Attention: James F. Clouser, President
and Chief Executive Officer
with a copy to: Gunderson Dettmer Stough Villeneuve
Franklin & Hachigian, LLP
155 Constitution Drive
Menlo Park, California 94025
Telecopier: (650) 321-2800
Attention: Carla S. Newell, Esq.
Jay K. Hachigian, Esq.
36
<PAGE>
or to such other address as the person to whom notice is given may have
previously furnished to the others in writing in the manner set forth above.
SECTION 10.5. Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware without regard to
the principles of conflicts of law thereof. Each of the parties hereto
irrevocably consents to the exclusive jurisdiction of any state or federal court
within Delaware, in connection with any matter based upon or arising out of this
Agreement or the matters contemplated herein, other than issues involving the
corporate governance of any of the parties hereto, agrees that process may be
served upon them in any manner authorized by the laws of the State of Delaware
for such persons and waives and covenants not to assert or plead any objection
which they might otherwise have to such jurisdiction and such process.
SECTION 10.6. Descriptive Headings. The descriptive headings herein are
inserted for convenience of reference only and are not intended to be part of or
to affect the meaning or interpretation of this Agreement.
SECTION 10.7. Parties in Interest. This Agreement shall be binding upon and
inure solely to the benefit of each party hereto and its successors and
permitted assigns and nothing in this Agreement express or implied is intended
to or shall confer upon any other person any rights, benefits or remedies of any
nature whatsoever under or by reason of this Agreement.
SECTION 10.8. Certain Definitions. For the purposes of this Agreement the
term:
(a) "affiliate" means a person that, directly or indirectly, through one or
more intermediaries controls, is controlled by or is under common control with
the first-mentioned person;
(b) "business day" means any day other than a day on which there is no
trading on Nasdaq;
(c) "stock" means common stock, preferred stock, partnership interests,
limited liability company interests or other ownership interests entitling the
holder thereof to vote with respect to matters involving the issuer thereof;
(d) "person" means an individual, corporation, partnership, limited
liability company, association, trust, unincorporated organization or other
legal entity; and
(e) "subsidiary" or "subsidiaries" of the Company, Parent, the Surviving
Corporation or any other person means any corporation, partnership, limited
liability company, association, trust, unincorporated association or other legal
entity of which the Company, Parent, the Surviving Corporation or any such other
person, as the case may be, (either alone or through or together with any other
subsidiary) owns, directly or indirectly, 50% or more of the capital stock the
holders of which are generally entitled to vote for the election of the board of
directors or other governing body of such corporation or other legal entity.
SECTION 10.9. Personal Liability. This Agreement shall not create or be
deemed to create or permit any personal liability or obligation on the part of
any direct or indirect stockholder of the Company or Parent or any officer,
director, employee, agent, representative or investor of any party hereto.
37
<PAGE>
SECTION 10.10. Specific Performance. The parties hereby acknowledge and
agree that the failure of any party to perform its agreements and covenants
hereunder, including its failure to take all actions as are necessary on its
part to the consummation of the Merger, will cause irreparable injury to the
other parties, for which damages, even if available, will not be an adequate
remedy. Accordingly, each party hereby consents to the issuance of injunctive
relief by any court of competent jurisdiction to compel performance of such
party's obligations and to the granting by any court of the remedy of specific
performance of its obligations hereunder; provided, however, that if a party
hereto is entitled to receive the Termination Fee pursuant to Section 9.3 it
shall not also be entitled to specific performance to compel the consummation of
the Merger.
SECTION 10.11. Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall be deemed to be an original but all of which
shall constitute one and the same agreement.
<PAGE>
IN WITNESS WHEREOF, each of the parties has caused this Agreement to be
duly executed on its behalf as of the day and year first above written.
ION BEAM APPLICATIONS S.A.
By: /s/ Pierre Mottet
----------------------------------
Name: Pierre Mottet
Title: Chief Executive Officer
ION BEAM APPLICATIONS G.P.
ION BEAM APPLICATIONS S.A.
Its General Partner
By: /s/ Pierre Mottet
----------------------------------
Name: Pierre Mottet
Title:
IBA ACQUISITION CORP.
By: /s/ Pierre Mottet
----------------------------------
Name: Pierre Mottet
Title:
STERIGENICS INTERNATIONAL, INC.
By: /s/ James F. Clouser
----------------------------------
Name: James F. Clouser
Title: Chief Executive Officer
STOCKHOLDERS' AGREEMENT
THIS STOCKHOLDERS' AGREEMENT (the "Agreement") is dated as of June 10,
1999, by and among Ion Beam Applications S.A. ("Parent"), a corporation
organized under the laws of the Kingdom of Belgium, Ion Beam Applications G.P.
("GP"), a Delaware general partnership which is controlled by Parent, and IBA
Acquisition Corporation ("Acquisition"), a Delaware corporation which is
wholly-owned by GP, and the stockholders listed on Schedule I hereto (each, a
"Stockholder," and collectively, the "Stockholders") of SteriGenics
International, Inc. (the "Company"), a Delaware corporation. Capitalized terms
used and not defined herein have the respective meanings assigned to them in the
Merger Agreement (defined herein).
WHEREAS, concurrently herewith, Parent, GP, Acquisition and the Company are
entering into a Merger Agreement, the form of which is appended hereto as
Exhibit A (as such agreement may hereafter be amended from time to time, the
"Merger Agreement"), pursuant to which the Offer will be made by Acquisition for
the issued and outstanding Shares of the Company, and Acquisition will be merged
with and into the Company (the "Merger");
WHEREAS, each Stockholder Beneficially Owns (defined herein) the number of
shares, par value $0.01 per share, of common stock (the "Common Stock") of the
Company (the "Shares") set forth opposite each Stockholder's name on Schedule I
hereto;
WHEREAS, as an inducement and a condition to entering into the Merger
Agreement, Parent and Acquisition have required that each Stockholder agree, and
each Stockholder has agreed, to enter into this Agreement.
NOW, THEREFORE, in consideration of the foregoing and the mutual premises,
representations, warranties, covenants and agreements contained herein, the
parties hereby agree as follows:
Section 1. Agreement to Vote; Irrevocable Proxy.
(a) Each Stockholder hereby agrees that during the period commencing as of
the date of this Agreement and continuing until the first to occur of the
Closing Time or 45 days after the termination of the Merger Agreement in
accordance with its terms, at any meeting of the holders of the Shares, however
called, or in connection with any written consent of the holders of Shares, each
Stockholder shall vote (or cause to be voted) the Shares held of record or
Beneficially Owned (as defined herein) by each Stockholder, whether owned on the
date hereof or hereafter acquired, (i) in favor of approval of the Merger
Agreement, all transactions contemplated thereby, and any actions required in
furtherance thereof and hereof (including election of such directors of the
Company as Parent is entitled to designate pursuant to the Merger Agreement);
(ii) against any action or agreement that is intended, or could reasonably be
expected, to impede, interfere with, or prevent the Offer or the Merger or
result in a breach in any
<PAGE>
respect of any covenant, representation or warranty or any other obligation or
agreement of the Company or any of its subsidiaries under the Merger Agreement
or this Agreement; and (iii) except as specifically requested in writing in
advance by Parent, against the following actions (other than the Merger and the
transactions contemplated by the Merger Agreement and this Agreement): (A) any
extraordinary corporate transaction, such as a merger, consolidation or other
business combination involving the Company or any of its subsidiaries or
affiliates; (B) a sale, lease, transfer or disposition by the Company or any of
its subsidiaries of any assets outside the ordinary course of business or any
assets which in the aggregate are material to the Company and its subsidiaries
taken as a whole, or a reorganization, recapitalization, dissolution or
liquidation of the Company or any of its subsidiaries or affiliates; (C)(1) any
change in the present capitalization of the Company or any amendment of the
Company's charter or By-Laws; (2) any other material change in the Company's or
any of its subsidiaries' corporate structure or business; or (3) any other
action that, in the case of each of the matters referred to in clauses (C)(1),
(2) or (3), is intended, or could reasonably be expected, to impede, interfere
with, delay, postpone or materially adversely affect the Offer, the Merger or
the transactions contemplated by this Agreement or the Merger Agreement. None of
the Stockholders shall enter into any agreement or understanding with any Person
(as defined herein) the effect of which would be inconsistent with or violative
of the provisions and agreements contained in Section 1 or 2 hereof.
(b) By his execution hereof and in order to secure his obligations
hereunder, each Stockholder hereby grants to, and appoints Pierre Mottet and
Yves Jongen, in their respective capacities as officers of Parent, and any
individual who shall hereafter succeed to any such office of Parent, and any
other designee of Parent, and each of them individually, each Stockholder's true
and lawful irrevocable (until the earlier of the Closing Time or 45 days after
the termination of the Merger Agreement in accordance with its terms (the
"Termination Date")) proxy and attorney-in-fact (with full power of
substitution) to vote the Shares, or grant a consent or approval in respect of
such Shares, as indicated in Section 1(a) above; effective immediately upon the
execution of this Agreement. Each Stockholder intends this proxy to be
irrevocable (from the date of this Agreement until the Termination Date) and
coupled with an interest and will take such further action and execute such
other instruments as may be necessary to effectuate the intent of this proxy and
hereby represents that any proxy heretofore given in respect of his Shares is
not irrevocable, and hereby revokes any proxy previously granted by each
Stockholder with respect to the Shares. Each Stockholder understands and
acknowledges that Parent and Acquisition are entering into the Merger Agreement
in reliance on such Stockholder's execution and delivery of this irrevocable
proxy. Each Stockholder hereby affirms that this irrevocable proxy is given in
connection with the execution of this Agreement and the Merger Agreement, and
further affirms that this irrevocable proxy is coupled with an interest in this
Agreement for the term stated herein and may under no circumstances be revoked.
Each Stockholder hereby ratifies and confirms all that this irrevocable proxy
may
2
<PAGE>
lawfully do or cause to be done by virtue hereof. This proxy is executed and
intended to be irrevocable in accordance with the provisions of Section 212(e)
of the Delaware General Corporation Law. This proxy shall terminate
automatically on the Termination Date.
Section 2. Other Covenants, Representations and Warranties.
Each Stockholder hereby represents, warrants and covenants to Parent and
Acquisition as of the date hereof and as of the Closing Time as follows:
(a) Ownership of Shares. Each Stockholder is the record and Beneficial
Owner of the number of Shares set forth opposite each Stockholder's name on
Schedule I hereto. On the date hereof, the Shares set forth opposite each
Stockholder's name on Schedule I hereto constitute all of the Shares owned of
record or Beneficially Owned by each Stockholder. Each Stockholder owns such
Shares free and clear of all liens, claims, charges, security interests,
mortgages or other encumbrances, and such Shares are subject to no rights of
first refusal, put rights, other rights to purchase or encumber such Shares, or
to any agreements other than this Agreement as to the encumbrance or disposition
of such Shares. Such Shares are duly and validly issued, fully paid and
non-assessable. Each Stockholder has sole voting power and sole power to issue
instructions with respect to the matters set forth in Section 1 hereof, sole
power of disposition, sole power of conversion, sole power to demand appraisal
rights and sole power to agree to all of the matters set forth in this
Agreement, in each case with respect to all of the Shares set forth opposite
each Stockholder's name on Schedule I hereto, with no limitations,
qualifications or restrictions on such rights.
(b) Power; Binding Agreement. Each Stockholder has the legal capacity,
power and authority to enter into and perform all of such Stockholder's
obligations under this Agreement. The execution, delivery and performance of
this Agreement by each Stockholder will not violate any other agreement to which
each Stockholder is a party including, without limitation, any voting agreement,
shareholder agreement or voting trust. This Agreement has been duly and validly
executed and delivered by each Stockholder and constitutes a valid and binding
agreement of each Stockholder, enforceable against each Stockholder in
accordance with its terms, except as such enforceability may be limited by any
applicable bankruptcy, insolvency, reorganization, moratorium or other similar
laws affecting the enforcement of creditors' rights generally, and except as the
availability of equitable remedies may be limited by the application of general
principles of equity (regardless of whether such equitable principles are
applied in a proceeding at law or in equity). There is no beneficiary or holder
of a voting trust certificate or other interest of any trust of which each
Stockholder is trustee who is not a party to this Agreement and whose consent is
required for the execution and delivery of this Agreement or the consummation by
each Stockholder of the transactions contemplated hereby. If any Stockholder is
married and such Stockholder's Shares constitute community property, this
Agreement has been duly authorized, executed and delivered by, and constitutes a
valid and binding
3
<PAGE>
agreement of, such Stockholder's spouse, enforceable against such person in
accordance with its terms, except as such enforceability may be limited by any
applicable bankruptcy, insolvency, reorganization, moratorium or other similar
laws affecting the enforcement of creditors' rights generally, and except as the
availability of equitable remedies may be limited by the application of general
principles of equity (regardless of whether such equitable principles are
applied in a proceeding at law or in equity).
(c) No Conflicts. (i) Except for filings, permits, authorizations, consents
and approvals as may be required under and other applicable requirements of the
HSR Act, no filing with, and no permit, authorization, consent or approval of,
any state or federal public body or authority is necessary for the execution of
this Agreement by each Stockholder and the consummation by each Stockholder of
the transactions contemplated hereby and (ii) none of the execution or delivery
of this Agreement by each Stockholder, the consummation by each Stockholder of
the transactions contemplated hereby or compliance by each Stockholder with any
of the provisions hereof shall (A) result in a violation or breach of, or
constitute (with or without notice or lapse of time or both) a default (or give
rise to any third party right of termination, cancellation, material
modification or acceleration) under any of the terms, conditions or provisions
of any note, bond, mortgage, indenture, license, contract, commitment,
arrangement, understanding, agreement or other instrument or obligation of any
kind to which each Stockholder is a party or by which each Stockholder or any of
such Stockholder's properties or assets may be bound, or (B) violate any order,
writ, injunction, decree, judgment, order, statute, rule or regulation
applicable to each Stockholder or any of each Stockholder's properties or
assets. This Agreement supersedes all prior agreements to which each Stockholder
is a party with respect to such Stockholder's Shares.
(d) No Finder's Fees. No broker, investment banker, financial adviser or
other person is entitled to any broker's, finder's, financial adviser's or other
similar fee or commission in connection with the transactions contemplated by
the Merger Agreement based upon arrangements made by or on behalf of any
Stockholder.
(e) Other Potential Acquirers. Each Stockholder (i) shall immediately cease
any existing discussions or negotiations, if any, with any parties conducted
heretofore with respect to any acquisition of all or any material portion of the
assets of, or any equity interest in, the Company or any of its subsidiaries or
any business combination with the Company or any of its subsidiaries, in his or
her capacity as such, and (ii) from and after the date hereof until termination
of the Merger Agreement in accordance with its terms, shall not, in its or his
capacity as a stockholder of the Company, directly or indirectly, initiate,
solicit or knowingly encourage (including by way of furnishing non-public
information or assistance), or take any other action to facilitate knowingly,
any inquiries or the making of any proposal that constitutes, or may reasonably
be expected to lead to, any such transaction or acquisition, or agree to or
endorse any such transaction or acquisition, or authorize or permit any of each
Stockholder's agents to do so, and each Stockholder shall promptly notify Parent
of any
4
<PAGE>
proposal and shall provide a copy of any such written proposal and a summary of
any oral proposal to Parent immediately after receipt thereof (and shall specify
the material terms and conditions of such proposal and identify the person
making such proposal) and thereafter keep Parent advised of any development with
respect thereto.
(f) Tender of Shares; Restriction on Transfer, Proxies and
Non-Interference. Each of the Stockholders shall tender his or its Shares in the
Offer (as defined in the Merger Agreement) and shall not withdraw such Shares
therefrom unless and until the Merger Agreement is terminated in accordance with
its terms without such Shares being purchased by Acquisition pursuant to the
Offer. None of the Stockholders shall, directly or indirectly: (i) tender his or
its Shares in any other tender offer or exchange offer for the Shares; (ii)
except as contemplated by this Agreement or the Merger Agreement, otherwise
offer for sale, sell, transfer, tender, pledge, encumber, assign or otherwise
dispose of, or enter into any contract, option or other arrangement or
understanding with respect to or consent to the offer for sale, sale, transfer,
tender, pledge, encumbrance, assignment or other disposition of, any or all of
any such Stockholder's Shares or any interest therein; (iii) grant any proxies
or powers of attorney, deposit any Shares into a voting trust or enter into a
voting agreement with respect to any Shares; or (iv) take any action that would
make any representation or warranty of any such Stockholder contained herein
untrue or incorrect or have the effect of preventing or disabling such
Stockholder from performing such Stockholder's obligations under this Agreement.
(g) Reliance by Parent and Acquisition. Each Stockholder understands and
acknowledges that Parent and Acquisition are relying upon the foregoing
representations, warranties and covenants by such Stockholder, and on each
Stockholder's execution and delivery of this Agreement in entering into the
Merger Agreement.
Section 3. Further Assurances; Merger Agreement Compliance.
From time to time, at Parent's request and without further consideration,
each Stockholder agrees to execute and deliver such additional documents and
take all such further lawful action as may be necessary or desirable to
consummate and make effective, and to cause the Company to consummate and make
effective, in the most expeditious manner practicable, the transactions
contemplated by this Agreement.
Section 4. Stop Transfer; Form of Legend.
(a) Each Stockholder agrees with, and covenants to, Parent that each
Stockholder shall not request that the Company register the transfer (book-entry
or otherwise) of any certificate or uncertificated interest representing any of
each Stockholder's Shares, without the consent of the Parent. In the event of a
stock dividend or distribution, or any change in the Shares by reason of any
stock dividend, split-up, recapitalization, combination, exchange of shares or
the like, the term "Shares"
5
<PAGE>
shall be deemed to refer to and include the Shares as well as all such stock
dividends and distributions and any shares into which or for which any or all of
the Shares may be changed or exchanged.
(b) If reasonably requested by Parent, all certificates representing any of
each Stockholder's Shares shall contain the following legend:
"The securities represented by this certificate
are subject to certain restrictions on transfer and
other terms of a Stockholders Agreement, dated as of
June 10, 1999, among Ion Beam Applications S.A., Ion
Beam Applications G.P., IBA Acquisition Corporation,
and the parties listed on the signatures pages thereto,
a copy of which is on file in the principal office of
Ion Beam Applications S.A."
Section 5. The Options.
Each Stockholder hereby agrees as follows:
(a) Grant of Options. Subject to the terms of this Section 5, each
Stockholder hereby grants to Parent (or its designee), effective upon the
execution hereof, an irrevocable option (each, an "Option") to purchase all
Shares held of record or Beneficially Owned by each such Stockholder at a
purchase price per Share equal to the greater of $27 or such higher price as may
be offered by Acquisition in the Offer (the "Option Price").
(b) Exercise of Options. Parent may exercise the Options, in whole or in
part, at any time and from time to time, following the occurrence of a Purchase
Event (as defined below); provided that any Options not theretofore exercised
shall expire and be of no further force and effect upon the earliest to occur
(the "Expiration Date") of (i) the Closing Time; (ii) forty-five days after the
first occurrence of a Purchase Event; or (iii) forty-five days after the
termination of the Merger Agreement in accordance with Section 9.1(c)(i), (ii)
or (iii) of the Merger Agreement; provided, however, that in the case of clauses
(ii) and (iii) above, the Expiration Date shall be extended for a period not to
extend beyond March 31, 2000 in the event that clearance under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act")
is required by Parent to acquire the Shares; provided, further that Parent is
using all reasonable efforts to obtain such clearance.
As used herein, a "Purchase Event" shall mean any of the following events
that occurs after the date hereof:
(i) Beneficial Ownership of more than 20% of the outstanding capital
stock of the Company (or rights to acquire such capital stock of the
6
<PAGE>
Company) shall have been acquired by any Person or "group" other than
Parent, Acquisition, or any affiliate of any of them;
(ii) the Company shall have entered into a definitive agreement or
approved or recommended any proposal which provides for the acquisition of
20% or more of the outstanding capital stock of the Company or
substantially all of the assets of the Company by any Person or group other
than Parent, Acquisition, or an affiliate of any of them;
(iii) (A) the failure of the Company's stockholders to approve the
Merger Agreement or the transactions contemplated thereby at a meeting
called to consider such Merger Agreement, if such meeting shall have been
preceded by (x) the public announcement by any Person or group (other than
Parent, Acquisition or an affiliate of any of them) of an offer or proposal
to acquire, merge or consolidate with the Company, or (y) the Board of
Directors of the Company publicly withdrawing or modifying, or publicly
announcing its intent to withdraw or modify, its recommendation that the
stockholders of the Company approve the transactions contemplated by the
Merger Agreement or (B) the acceptance by the Company' Board of Directors
of, or the public recommendation by the Company's Board of Directors that
the stockholders of the Company accept, an offer or proposal from any
Person or group (other than Parent, Acquisition or an affiliate of any of
them), to acquire 20% or more of the outstanding capital stock of the
Company or for a merger or consolidation or any similar transaction
involving the Company;
(iv) the making of an Acquisition Proposal as described in Section 5.3
of the Merger Agreement which would entitle Parent or the Company to
terminate the Merger Agreement pursuant to Section 9.1 of the Merger
Agreement; or
(v) any breach by the Stockholder of this Agreement.
(c) Notice of Exercise. To exercise an Option, Parent shall, prior to the
Expiration Date, give written notice to each Stockholder specifying the location
in Palo Alto, California and time for the closing (the "Option Closing") of such
purchase. The Option Closing shall be held on the date that is no later than
three business days after the date on which each of the conditions set forth in
Section 5(d) below has been satisfied or waived by Parent.
(d) Conditions to Option Closing Following Exercise of Options. The
occurrence of the Option Closing shall be subject to the satisfaction of each of
the following conditions:
7
<PAGE>
(i) to the extent necessary, any applicable waiting periods (and any
extension thereof) under the HSR Act with respect to the purchase of the
Shares following the exercise of an Option shall have expired or been
terminated; and
(ii) no preliminary or permanent injunction or other order, decree or
ruling issued by any court of governmental or regulatory authority,
domestic or foreign, of competent jurisdiction prohibiting the exercise of
an Option or the delivery of Shares shall be in effect.
The foregoing conditions may be waived solely by Parent, provided that no
Stockholder would incur any material liability as a result of such waiver.
(e) Transferability of Options. Parent may sell or transfer the Options and
any Shares acquired upon exercise of an Option at any time, without the written
consent of each Stockholder, to any affiliate or affiliates of Parent,
Acquisition or an affiliate of any of them.
(f) Payment for and Delivery of Certificates. At the Option Closing, (i)
Parent (or its designee) shall pay, by check, an amount equal to the product of
(x) the Option Price and (y) the number of Shares owned by each Stockholder; and
(ii) each Stockholder shall deliver or shall cause to be delivered to Parent a
certificate or certificates evidencing each Stockholder's Shares, and each
Stockholder agrees that such Shares shall be transferred free and clear of all
liens. All such certificates representing Shares shall be duly endorsed in
blank, or with appropriate stock powers, duly executed in blank, attached
thereto, in proper form for transfer, with the signature of each Stockholder
thereon guaranteed, and with all applicable taxes paid or provided for.
Section 6. Termination.
Except as otherwise provided herein, the covenants and agreements contained
herein with respect to the Shares shall terminate upon the earliest of (a)
termination of the Merger Agreement in accordance with its terms, or (b) the
Effective Time.
Section 7. Stockholder Capacity.
No person executing this Agreement who is or becomes during the term hereof
a director or executive officer of the Company makes any agreement or
understanding herein in his or her capacity as such director or executive
officer. Each Stockholder signs solely in his capacity as the record and/or
beneficial owner of each Stockholder's Shares.
Section 8. Waiver of Appraisal and Dissenter's Rights.
Each Stockholder hereby irrevocably waives any rights of appraisal or
rights to dissent from the Merger that each Stockholder may have.
8
<PAGE>
Section 9. Miscellaneous.
(a) Certain Definitions. As used in this Agreement, the following
capitalized terms shall have the following meanings:
(i) "Beneficially Own" or "Beneficial Ownership" with respect to any
securities shall mean having "beneficial ownership" of such securities (as
determined pursuant to Rule 13d-3 under the Exchange Act), including
pursuant to any agreement, arrangement or understanding, whether or not in
writing. Without duplicative counting of the same securities by the same
holder, securities Beneficially Owned by a Person shall include securities
Beneficially Owned by all other Persons with whom such Person would
constitute a "group" as within the meanings of Section 13(d)(3) of the
Exchange Act.
(ii) "Misstatement" means an untrue statement of a material fact or an
omission to state a material fact required to be stated in a publicly-filed
document necessary to make the statements in such a document not
misleading.
(iii) "Person" shall mean an individual, corporation, partnership,
joint venture, association, trust, unincorporated organization or other
entity.
(iv) "register," "registered," and "registration" refer to a
registration effected by preparing and filing with the SEC a registration
statement in compliance with the Securities Act and the declaration or
ordering by the SEC of effectiveness of such registration statement.
(v) "subsidiary" or "subsidiaries" of Parent, Acquisition, the Company
or any other person means any corporation, partnership, limited liability
company, association, trust, unincorporated association or other legal
entity of which the Parent, Acquisition, the Company or any such other
person, as the case may be, (either alone or through or together with any
other subsidiary) owns, directly or indirectly, 50% or more of the capital
stock the holders of which are generally entitled to vote for the election
of the board of directors or other governing body of such corporation or
other legal entity.
(b) Entire Agreement. This Agreement and the Merger Agreement constitute
the entire agreement between the parties with respect to the subject matter
hereof and supersede all other prior agreements and understandings, both written
and oral, between the parties with respect to the subject matter hereof.
(c) Certain Events. Each Stockholder agrees that this Agreement and the
obligations hereunder shall attach to each Stockholder's Shares and shall be
binding upon any person or entity to which legal or beneficial ownership of such
Shares shall pass, whether by operation of law or otherwise, including, without
limitation, each
9
<PAGE>
Stockholder's heirs, guardians, administrators or successors. Notwithstanding
any transfer of Shares, the transferor shall remain liable for the performance
of all obligations under this Agreement of the transferor.
(d) Assignment. This Agreement may not be assigned by any Stockholder
without the consent of Parent. Parent may assign, in its sole discretion, its
rights and obligations hereunder to any direct or indirect wholly-owned
subsidiary of Parent, but no such assignment shall relieve Parent of its
obligations hereunder if such assignee does not perform such obligations.
(e) Amendments, Waivers, Etc. This Agreement may not be amended, changed,
supplemented, waived or otherwise modified or terminated, with respect to each
Stockholder, except upon the execution and delivery of a written agreement
executed by the relevant parties hereto; provided that Schedule I hereto may be
supplemented by Parent by adding the name and other relevant information
concerning any stockholder of the Company who agrees to be bound by the terms of
this Agreement (by executing a counterpart signature page hereof) without the
agreement of any other party hereto, and thereafter such added stockholder shall
be treated as a "Stockholder" for all purposes of this Agreement.
(f) Notices. All notices, requests, claims, demands and other
communications hereunder shall be in writing and shall be given (and shall be
deemed to have been duly received if so given) by hand delivery, telegram, telex
or telecopy, or by mail (registered or certified mail, postage prepaid, return
receipt requested) or by any courier service, such as Federal Express, providing
proof of delivery. All communications hereunder shall be addressed to the
respective parties at the following addresses:
If to each Stockholder: At the address set forth on Schedule I
hereto.
If to Parent or Acquisition: Ion Beam Applications S.A.
Chemin du Cyclotron, 3
B-1348 Louvain-la-Neuve, Belgium
Telephone: 011-32-10-47-5855
Telecopier: 011-32-10-47-5810
Attention: Mr. Pierre Mottet, Chief
Executive Officer
with a copy to: Dorsey & Whitney LLP
250 Park Avenue
New York, NY 10177
Telephone: (212) 415-9200
Telecopier: (212) 953-7201
Attention: Ramon P. Marks, Esq.
10
<PAGE>
or to such other address as the person to whom notice is given may have
previously furnished to the others in writing in the manner set forth above.
(g) Severability. Whenever possible, each provision or portion of any
provision of this Agreement will be interpreted in such manner as to be
effective and valid under applicable law, but if any provision or portion of any
provision of this Agreement is held to be invalid, illegal or unenforceable in
any respect under any applicable law or rule in any jurisdiction, such
invalidity, illegality or unenforceability will not affect any other provision
or portion of any provision in such jurisdiction, and this Agreement will be
reformed, construed and enforced in such jurisdiction as if such invalid,
illegal or unenforceable provision or portion of any provision had never been
contained herein.
(h) Specific Performance. Each of the parties hereto recognizes and
acknowledges that a breach by it of any covenants or agreements contained in
this Agreement will cause the other party to sustain damages for which it would
not have an adequate remedy at law for money damages, and therefore each of the
parties hereto agrees that in the event of any such breach the aggrieved party
shall be entitled to the remedy of specific performance of such covenants and
agreements and injunctive and other equitable relief in addition to any other
remedy to which it may be entitled, at law or in equity.
(i) Remedies Cumulative. All rights, powers and remedies provided under
this Agreement or otherwise available in respect hereof at law or in equity
shall be cumulative and not alternative, and the exercise of any thereof by any
party shall not preclude the simultaneous or later exercise of any other such
right, power or remedy by such party.
(j) No Waiver. The failure of any party hereto to exercise any right, power
or remedy provided under this Agreement or otherwise available in respect hereof
at law or in equity, or to insist upon compliance by any other party hereto with
its obligations hereunder, and any custom or practice of the parties at variance
with the terms hereof, shall not constitute a waiver by such party of its right
to exercise any such or other right, power or remedy or to demand such
compliance.
(k) No Third Party Beneficiaries. This Agreement is not intended to be for
the benefit of, and shall not be enforceable by, any person or entity who or
which is not a party hereto.
(l) Governing Law. This Agreement shall be governed and construed in
accordance with the laws of the State of Delaware, without giving effect to the
principles of conflicts of laws thereof.
11
<PAGE>
(m) Descriptive Headings. The descriptive headings used herein are inserted
for convenience of reference only and are not intended to be part of or to
affect the meaning or interpretation of this Agreement.
(n) Counterparts. This Agreement may be executed in counterparts, each of
which shall be deemed to be an original, but all of which, taken together, shall
constitute one and the same Agreement.
12
<PAGE>
IN WITNESS WHEREOF, Parent and Acquisition have caused this Agreement to be
duly executed, and each Stockholder has duly executed this Agreement, as of the
day and year first above written.
ION BEAM APPLICATIONS S.A.
By: /s/ Pierre Mottet
---------------------------------
Pierre Mottet
Chief Executive Officer
ION BEAM APPLICATIONS G.P.
By: ION BEAM APPLICATIONS S.A.,
Its Partner
By: /s/ Pierre Mottet
---------------------------------
Pierre Mottet
Chief Executive Officer
IBA ACQUISITION CORP.
By: /s/ Pierre Mottet
---------------------------------
Pierre Mottet
<PAGE>
STOCKHOLDERS:
<PAGE>
Schedule I
<TABLE>
<CAPTION>
Number of
Name of Stockholder Address Shares Owned
------------------- ------- ------------
<S> <C> <C>
The Charles W. King, Jr. Revocable 405 Alberto Way, Suite 5 20,962
Trust Dated December 17, 1986 Los Gatos, California 95032
The Charles W. King, III Trust 405 Alberto Way, Suite 5 81,050
Dated April 15, 1983 Los Gatos, California 95032
The Michael James King Trust 405 Alberto Way, Suite 5 81,050
Dated April 15, 1983 Los Gatos, California 95032
The Patricia M. King Trust 405 Alberto Way, Suite 5 81,050
Dated April 15, 1983 Los Gatos, California 95032
KFFP II, L.P., a California 405 Alberto Way, Suite 5 400,000
Limited Partnership Los Gatos, California 95032
KFFP III, L.P., a California 405 Alberto Way, Suite 5 1,800,000
Limited Partnership Los Gatos, California 95032
The King Family Trust 405 Alberto Way, Suite 5 30,200
Dated December 16, 1997 Los Gatos, California 95032
</TABLE>
<PAGE>
EXHIBIT A
MERGER AGREEMENT
TRANSLATION
ION BEAM APPLICATIONS SA
PRESS RELEASE
MAJOR NEW ACQUISITION FOR
IBA IN THE US STERILIZATION MARKET
Louvain-la-Neuve, 11 June 1999
Ion Beam Applications S.A. (IBA), has just concluded an agreement to acquire
SteriGenics International, Inc. (NASDAQ:STER).
SteriGenics, which is based in Fremont, California, has developed a position of
leadership in the area of sterilization services of medical devices and food
products and for polymer modification by using gamma radiation. The acquisition
cost is approximately US$ 214 million. Under the terms of the agreement, the
shareholders of SteriGenics will receive US$ 27 per share in cash. IBA expects
to commence a tender offer within the next 5 business days. The Boards of
Directors of both companies have approved the transaction.
IBA, which first developed as an equipment manufacturer, made its entry in the
services industry through the acquisition in May 1999 of Griffith Micro
Sciences, a leader in Eto (Ethylene oxide) sterilization services, and is
present in almost a dozen countries, and whose HQ is in Chicago.
The acquisition of SteriGenics will allow IBA further to expand the range of
technologies it offers its customers. According to Pierre Mottet, CEO of IBA:
"The acquisition of SteriGenics will allow us to offer our customers the
complete choice of technology which they need, including Eto, electron beam,
X-ray and Gamma. It will also allow us to open the door of new markets and new
clients". James F. Clouser, CEO of SteriGenics, added: "The combination of IBA
and SteriGenics will contribute efficiently to the increasing demands of our
customers for 'one-stop shopping' for the medical device sterilization, food
pasteurization and polymer modification industries".
The closing of the offer is expected to occur in July 1999, subject to necessary
applicable regulatory approvals. This acquisition fits particularly well with
IBA's growth strategy by expanding its range of technologies in order to cover
more applications in the markets where it is active.
IBA is principally active in 4 areas: cancer radio-therapy, the production of
radio-isotopes for medical imagery, sterilization of medical devices and food
products and the improvement of
<PAGE>
materials through radiation. With this acquisition, the group should comprise
1,100 people and should have a turnover of more than 150 million in 1999.
SteriGenics, which is located at 15 sites in the USA, had a turnover, in its
last financial year which ended 31 March 1999, of US$ 55 million and a net
profit, after tax, of US$ 7.8 million.
You can find further information on IBA at "www.IBA.be" and on SteriGenics at
"www.sterigenics.com".
For more information contact:
Eric de Lamotte
Chief Financial Officer
IBA
Tel: +32 10 475 807
E-mail: [email protected]
